{"allowContribute":false,"item":{"activeCommit":"973bb80962d4919df586c15e10a3ca174662bf96","apis":{"routes":[{"method":"POST","path":"/api/send-combined-by-id"},{"method":"POST","path":"/api/send-email"}],"types":{"SendResult":"interface SendResult { email: string; ok: boolean; messageId?: string; error?: string; attempts: number; }"}},"backendSchedules":[],"bundleHash":"da7f065d8271ce38","createdAt":1782497323036,"deletedAt":null,"displayName":"醫療概念股面板","exampleHintSeen":true,"gitCommit":"973bb80962d4919df586c15e10a3ca174662bf96","id":"cad183ec663244f61c1f6258","isPublic":true,"itemType":"PLUGIN","name":"醫療概念股面板","parents":{},"pluginDir":"醫療概念股面板","preParentID":null,"repositoryID":"repo_3b5799ff2c0d05dfbd367cd4","status":"active","updatedAt":1788748839355,"updatedBy":{"userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":73},"ownerMemberId":"6a3d974d01591e0e744b8c","ownerName":"Ivan","publicPlugins":{"PLUGIN":{"pluginItemId":"cad183ec663244f61c1f6258","pluginDir":"醫療概念股面板","bundleHash":"da7f065d8271ce38","live":false}},"subtree":[{"activeCommit":"973bb80962d4919df586c15e10a3ca174662bf96","apis":{"routes":[{"method":"POST","path":"/api/send-combined-by-id"},{"method":"POST","path":"/api/send-email"}],"types":{"SendResult":"interface SendResult { email: string; ok: boolean; messageId?: string; error?: string; attempts: number; }"}},"backendSchedules":[],"bundleHash":"da7f065d8271ce38","createdAt":1782497323036,"deletedAt":null,"displayName":"醫療概念股面板","exampleHintSeen":true,"gitCommit":"973bb80962d4919df586c15e10a3ca174662bf96","id":"cad183ec663244f61c1f6258","isPublic":true,"itemType":"PLUGIN","name":"醫療概念股面板","parents":{},"pluginDir":"醫療概念股面板","preParentID":null,"repositoryID":"repo_3b5799ff2c0d05dfbd367cd4","status":"active","updatedAt":1788748839355,"updatedBy":{"userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":73},{"createdAt":1789942278464,"event":"openPR 9/9：美國醫材包裝市場展望至2033，關鍵監管為FDA 2026年ISO 11607-1/-2過渡（認可2023修訂版）；另有合規大限2026/12/20起FDA不再接受舊版符合性聲明。","id":"301b3d957630cab7c4931d08","impact":"ISO 11607新版過渡進入倒數3個月，未完成驗證的包材廠面臨輸美門檻；包裝確效＋驗證需求爆發，檢測鏈受惠。","itemType":"MEDICAL_NEWS","name":"FDA ISO 11607新版過渡 12/20起不再接受舊版聲明（9/9）","newsDate":"2026/09/09","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1789942278664},"relatedStocks":"STE","sourceUrl":"https://www.openpr.com/news/4627085/u-s-medical-device-packaging-market-2033-fda-packaging","updatedAt":1789942278464,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789942278464,"event":"FDF商業指南（9/2更新）：PPWR全面改革包裝設計／標籤／重用／回收要求，8/12/2026起首波適用；Healthcare Packaging 8/27：8月大限聚焦基線資料建檔（完整包裝組合盤點＋申報）；LinkedIn Neeta Verma 9/8整理EC 8/12後澄清要點。","id":"93205bb5ef9d9a8a6cf4b03c","impact":"PPWR由紙面進入執法期：基線申報＋EPR＋海關查驗三步驟為合規核心；輸歐包材廠（中／泰／台）合規成本上升，率先達標者取轉單。","itemType":"MEDICAL_NEWS","name":"PPWR進入執法期 EC發布8/12後澄清＋基線申報要求（9/2-8）","newsDate":"2026/09/08","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1789942278764},"relatedStocks":"","sourceUrl":"https://www.fdf.org.uk/fdf/business-guidance-hubs/packaging/ppwr-business-guidance-page/","updatedAt":1789942278464,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789942278464,"event":"Emergo 9/19、ChinaMedDevice 9/8、meddeviceguide 9/8：NMPA修訂版《醫療器械生產質量管理規範》（GMP公告107號）11/1/2026全面生效，涉生產許可（53號令）vs GMP雙軌、雙人放行、全職關鍵人員門檻；8月進口暫停執法案已為過渡暖身。","id":"5305034a9f5731e5b51ecef9","impact":"NMPA新QMS倒數6週：境內外廠（含滅菌包材供應鏈）須完成雙放行＋關鍵人員＋受託生產合規；未達標面臨進口暫停，包裝滅菌列製造焦點。","itemType":"MEDICAL_NEWS","name":"NMPA新版GMP 11/1生效倒數 雙放行＋關鍵人員門檻（9/8-19）","newsDate":"2026/09/19","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1789942278964},"relatedStocks":"","sourceUrl":"https://www.emergobyul.com/news/china-nmpa-quality-management-system-qms-legislation-take-effect-november-1-2026","updatedAt":1789942278464,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789942278464,"event":"PackagingDigest 9/4：FDA 8月發布《人類藥品與生物製品容器密封系統》指南草案（Container Closure Systems），規範無菌屏障＋密封完整性要求；為2026年包裝確效系列新指引之一。","id":"a66a56cfd8c817c52b3ace01","impact":"容器密封＋無菌屏障合規門檻再墊高，包裝確效（ISO 11607）壁壘強化；FDA召回從嚴連動，利好檢測與高階包材。","itemType":"MEDICAL_NEWS","name":"FDA發布容器密封系統指南草案 密封完整性新規（9/4）","newsDate":"2026/09/04","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1789942278464},"relatedStocks":"MDLN,STE","sourceUrl":"https://www.packagingdigest.com/pharmaceutical-packaging/fda-releases-new-guidance-on-drug-biologic-container-closure-systems","updatedAt":1789942278464,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789942278464,"event":"FDA 9/1更新PFAS指引：基於現有科學研究，無理由限制含氟聚合物（fluoropolymers）在醫材的持續使用；MDDI Online 9/15指出FDA與EU對PFAS釋出矛盾訊號（歐盟趨嚴、FDA放行）。","id":"fc0fd2ce5062aafc6ccee827","impact":"美歐PFAS監管分歧：出口歐盟仍須面對PPWR＋PFAS禁令，輸美則鬆綁；含氟包材／塗層廠須採雙軌合規策略。","itemType":"MEDICAL_NEWS","name":"FDA更新PFAS指引放行含氟聚合物 與EU矛盾訊號（9/1-15）","newsDate":"2026/09/15","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1789942278564},"relatedStocks":"DD","sourceUrl":"https://www.mddionline.com/materials/fda-and-eu-send-conflicting-messages-on-pfas-use-in-medical-devices","updatedAt":1789942278464,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789942278464,"event":"Goodwin 9/11、UL 9/10、Taylor Wessing 9/7、PrivacyWorld 9/7一致確認：CRA通報義務9/11正式生效，在歐盟市場投放聯網產品者須通報被積極利用漏洞與嚴重事件；為首個硬性時點，罰則＋合規步驟明確。","id":"5f61cdfab49db3a358f635f8","impact":"聯網醫材（Hugo、監護、CGM、影像）在歐上市須建漏洞通報＋SBOM＋支援期更新體系；MDT、SNN等數位化廠商合規成本上升、先行者成護城河。","itemType":"MEDICAL_NEWS","name":"歐盟CRA通報義務9/11生效 聯網醫材須申報漏洞（9/7-11）","newsDate":"2026/09/11","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1789942278864},"relatedStocks":"MDT,SNN","sourceUrl":"https://www.goodwinlaw.com/en/insights/publications/2026/09/alerts-lifesciences-technology-preparing-for-eu-cyber-resilience-act","updatedAt":1789942278464,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789942249011,"event":"GEO優化白皮書（9/15前後）：NMPA創新器械累計431個獲批（至2026/6）；6批國家組織高值耗材集採覆蓋9大類142種；藥械組合產品FDA/EMA/NMPA分類判定與審評路徑指南（9/6）同步出爐。","id":"6b3e7cb490f94e1bf47340b6","impact":"集採常態化壓價＋創新器械加速並行：以量補價成中國耗材主旋律，滅菌包材以價換量壓力延續；組合產品路徑明確利好跨境取證。","itemType":"MEDICAL_NEWS","name":"中國集採6批142種＋創新器械431個獲批 組合產品路徑指南（9/15）","newsDate":"2026/09/15","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789942249211},"relatedStocks":"","updatedAt":1789942249011,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789942249011,"event":"FinLab量化（9/20）：點名醫療包材具中期支撐（高齡化＋醫材＋製藥需求），子公司欣德芮規劃宜蘭科學園區設廠，主攻醫療器械滅菌袋、藥廠無菌包材。","id":"67c67508cfb35dcaae077399","impact":"台廠切入滅菌袋／無菌包材獲資金關注；呼應8215明基材9/18大漲＋9.2%至NT$27.35（+9.18%）領漲亞洲線。","itemType":"MEDICAL_NEWS","name":"台廠切入醫療滅菌袋 欣德芮規劃宜蘭設廠（9/20）","newsDate":"2026/09/20","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789942249411},"relatedStocks":"8215","updatedAt":1789942249011,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789942249011,"event":"Global Info Research發布《2026世界醫藥品用內包裝材料市場變革與趨勢洞察》：市場CAGR 5.2%至2032年達64,190（百萬日圓口徑）；先進包材企業加碼高附加價值生物醫藥領域產能，中國本土廠藉一致性評價擴張。","id":"223e8f1ffea97fb485205136","impact":"內包材升級（高阻隔膜、預灌封、BFS）需求明確；生物製藥＋無菌製劑拉動Tyvek／高阻隔包材鏈（DD、Nipro系）中線動能。","itemType":"MEDICAL_NEWS","name":"全球醫藥內包材市場CAGR5.2%至2032年 生物藥拉動升級（9/17）","newsDate":"2026/09/17","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789942249011},"relatedStocks":"DD","updatedAt":1789942249011,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789942249011,"event":"亞太教育訓練網9/9課程表：9/15台北＋線上開辦醫療器材微生物檢驗與實驗室管理（ISO 11737滅菌確效）、9/17醫療器材人因可用性；滅菌確效在地能量升溫。","id":"41ad270525b19e8a03e24694","impact":"台灣醫材滅菌確效＋人因工程合規需求升溫，呼應FDA人因最終指引（eSTAR）與ISO 11607包裝確效壁壘；利好檢測與包材驗證鏈。","itemType":"MEDICAL_NEWS","name":"台灣9/15滅菌確效＋9/17人因可用性研習班開辦（9/9）","newsDate":"2026/09/09","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789942249311},"relatedStocks":"8215","updatedAt":1789942249011,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789942249011,"event":"歐美醫材包裝展望延續：美國無菌包裝$6.37B→$15B（CAGR近9%）、滅菌袋與單一材質升級（CPP薄膜＋回收含量路徑）為9月主旋律；歐洲在地化＋PPWR合規推升區域產能。","id":"22f12873e6f52dd2d49d0cd9","impact":"包裝材料升級＋區域產能雙主線延續；美歐包材鏈（DD Tyvek、STE滅菌、歐系廠）中線受惠，短線隨大盤整理。","itemType":"MEDICAL_NEWS","name":"美歐醫材包裝升級延續 無菌袋＋單一材質為主旋律（9月中旬）","newsDate":"2026/09/15","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789942249511},"relatedStocks":"DD,STE","updatedAt":1789942249011,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789942249011,"event":"IndexBox中文版（約9/17）：無菌試驗驗證套組市場2026-2035基準情境CAGR 6-9%，市場指數達185（2025=100）；受監管產業無菌保證需求升溫，半導體級品質要求外溢。","id":"206ad838d68edb4ef1abf69a","impact":"滅菌確效＋驗證耗材需求穩增，呼應無菌屏障完整性測試（ASTM/ISO 11607）合規主線；利好滅菌包材與檢測鏈。","itemType":"MEDICAL_NEWS","name":"無菌試驗驗證套組市場CAGR6-9%至2035 半導體級需求外溢（9/17）","newsDate":"2026/09/17","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789942249111},"relatedStocks":"STE","updatedAt":1789942249011,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789942225341,"event":"9/17官方宣布董事Kenneth Gardner-Smith出任新任總裁兼CEO（Q4初到任，年薪$1M＋130%獎金目標＋$6M激勵與簽約獎），同步新增首席商務官；兌現8-K繼任程序承諾（9月中前公布）。","id":"1aa76209062b40bd40d1230e","impact":"ACH人事不確定性落地，但股價9/18崩-13.6%至$0.89創掛牌新低、再臨Nasdaq $1合規風險；新CEO turnaround執行力為下一棒首要追蹤。","itemType":"MEDICAL_NEWS","name":"ACH任命Kenneth Gardner-Smith為新CEO Q4初上任（9/17）","newsDate":"2026/09/17","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789942225641},"relatedStocks":"ACH","sourceUrl":"https://uk.finance.yahoo.com/news/accendra-health-names-kenneth-gardner-103000681.html","updatedAt":1789942225341,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789942225341,"event":"The Nation 9/9：泰國目標吸引逾680億銖醫療投資，規劃與MSD簽約擴大臨床試驗；同週BOI批准約$29B投資潮（數據中心領銜，醫療列戰略產業）；Krungsri估泰國醫材市場年增6-7%至2027。","id":"edc3fc1422d3b586ae392ef3","impact":"泰國醫療聚落吸金＋臨床能量升級，呼應Benchmark加碼泰國高混合製造主線；滅菌包材／代工轉單受惠。","itemType":"MEDICAL_NEWS","name":"泰國拚680億銖醫療投資＋MSD臨床試驗合作（9/9）","newsDate":"2026/09/09","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789942225741},"relatedStocks":"","sourceUrl":"https://www.nationthailand.com/health-wellness/40070812","updatedAt":1789942225341,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789942225341,"event":"Deemed Consulting 9/12發布泰國Thai FDA醫材分類導讀：循AMDD四級風險分類（Class 1-4），附各級路徑、費用與ISO 13485要求；Thai FDA 2026法規＋UDI追溯籌備並行。","id":"027c4dd8fb610cb2a2d7e0bf","impact":"市場准入路徑明確化，外資醫材＋包材廠進泰國審批成本可預測；AMDD調和＋BOI優惠雙軌利多延續。","itemType":"MEDICAL_NEWS","name":"泰國Thai FDA醫材AMDD四級分類導讀＋UDI籌備（9/12）","newsDate":"2026/09/12","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789942225841},"relatedStocks":"","sourceUrl":"https://www.deemedconsulting.com/thai-fda-device-classification","updatedAt":1789942225341,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789942225341,"event":"Moore Law 9/15發布投資人行動通知鼓勵MDLN投資人聯繫律所；Kaplan Fox 9/16-17連續發布證券調查警報（援引6/3 Reuters：5/28 FDA警告信，CGMP重大違規、Tracy火災後第二封）；反向籌碼Baird 9/13加碼34.9萬股，多空分歧加劇。","id":"7ea890cf6f36bd6ff14f9bcc","impact":"MDLN單週-2.7%失守$32、9/18收$31.64逼近年低$32.39一線；訴訟立案風險＋警告信整改為後續核心追蹤點，包裝確效壁壘墊高同業門檻。","itemType":"MEDICAL_NEWS","name":"MDLN證券調查擴大＋Baird逆勢加碼34.9萬股（9/13-17）","newsDate":"2026/09/17","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789942225341},"relatedStocks":"MDLN","sourceUrl":"https://www.globenewswire.com/news-release/2026/09/15/3362620/0/en/investor-action-notice-moore-law-pllc-encourages-investors-in-medline-inc-to-contact-law-firm.html","updatedAt":1789942225341,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789942225341,"event":"MassDevice 9/19報導分析師背書MDT收購Cornerstone/Sentire：Needham認同Sentire可補強Hugo產品線；機器人手術市場仍有成長空間，交易強化MDT機器人手術地位。","id":"2064af77a86ccf24d47773ad","impact":"呼應MDT 7億結盟Cornerstone＋Hugo落地主線；MDT 9/18收$92.13（-0.7%）屬Q1上調後高檔整理，擴張題材支撐評價。","itemType":"MEDICAL_NEWS","name":"MDT收購Cornerstone獲分析師背書 補強Hugo機器人版圖（9/19）","newsDate":"2026/09/19","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789942225441},"relatedStocks":"MDT","sourceUrl":"https://www.massdevice.com/medtronic-strengthens-robotic-surgery-position-with-cornerstone-deal-analysts-say/","updatedAt":1789942225341,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789942225341,"event":"Yahoo Finance healthcare專欄（約9/17）討論是否買進MDT：Hugo手術系統正擴大適應症用途、擴張營收基礎；搭配FY27 Q1大勝＋上調全年展望。","id":"6ef58d9b7c329c821ee525ce","impact":"MDT中線成長敘事延續（Hugo＋心血管＋糖尿病三引擎）；短線9/18回檔-0.7%不改趨勢，下一棒追Hugo落地進度。","itemType":"MEDICAL_NEWS","name":"MDT Hugo手術機器人擴大適應症 營收基礎擴張（9/17）","newsDate":"2026/09/17","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789942225541},"relatedStocks":"MDT","sourceUrl":"https://finance.yahoo.com/healthcare/articles/buy-medtronic-stock-hugo-surgical-194300215.html","updatedAt":1789942225341,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789338476241,"event":"Terumo週跌7.6%為日股最弱：無公司新利空，8/7上調指引後獲利了結，9/29除息每股15日圓技術性壓抑","id":"710bddf223e13cb41dc131fe","impact":"屬漲多回檔，9/11收¥2,246低檔反彈0.49%","itemType":"MEDICAL_NEWS","name":"","newsDate":"2026/9/11","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789338476541},"relatedStocks":"4543","updatedAt":1789338476241,"updatedBy":{"agentId":"30f11a13bea3773252e54bd2","agentName":"醫療報告撰寫員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789338476241,"event":"弱勢組：STE跌破215週跌6.2%、CAH週跌5.1%，屬評價修正與資金輪動","id":"213aca7c29dd0c2671534126","impact":"滅菌需求本身未轉弱，短線超跌；STERIS失守215關口","itemType":"MEDICAL_NEWS","name":"","newsDate":"2026/9/11","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789338476441},"relatedStocks":"STE,CAH","updatedAt":1789338476241,"updatedBy":{"agentId":"30f11a13bea3773252e54bd2","agentName":"醫療報告撰寫員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789338476241,"event":"ACH守住1美元週跌10.7%：9月中繼任CEO公布時程倒數為短線最大變數","id":"a8fce38508aa4348b4e33589","impact":"守住1美元關口為首要觀察，8-K預告時程將至","itemType":"MEDICAL_NEWS","name":"","newsDate":"2026/9/11","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789338476641},"relatedStocks":"ACH","updatedAt":1789338476241,"updatedBy":{"agentId":"30f11a13bea3773252e54bd2","agentName":"醫療報告撰寫員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789338476241,"event":"FRE逆勢週漲3.2%：Q2超預期上調指引＋出售透析股權進帳3億歐元＋券商重申正面","id":"a6acdae22e3672487390db3b","impact":"三重題材推升為唯一連漲歐股，9/11收€45.04","itemType":"MEDICAL_NEWS","name":"","newsDate":"2026/9/11","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789338476341},"relatedStocks":"FRE","updatedAt":1789338476241,"updatedBy":{"agentId":"30f11a13bea3773252e54bd2","agentName":"醫療報告撰寫員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789338476241,"event":"美國醫療器材包裝展望至2034：FDA合規驅動高個位數成長","id":"4ff8c774cb57bff9feb570c2","impact":"滅菌包裝擴張趨勢明確，佐證DD、DNP、Zacros與Getinge、Sartorius設備鏈能見度","itemType":"MEDICAL_NEWS","name":"","newsDate":"2026/9/10","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789338476241},"relatedStocks":"DD,DNP,7917,GETI-B","updatedAt":1789338476241,"updatedBy":{"agentId":"30f11a13bea3773252e54bd2","agentName":"醫療報告撰寫員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789337206748,"event":"密封鋁箔獲豁免於歐盟繫留瓶蓋要求；DHL 更新 9 月海關監管動態，提示 PPWR 相關進口文件趨嚴","id":"c86f265214e7949a77afa70a","impact":"鋁箔封口泡罩袋裝產品鬆綁改造成本；但海關文件趨嚴，輸歐包材須備妥 EPR 與材質聲明","itemType":"MEDICAL_NEWS","name":"法規鋁箔豁免繫留蓋 DHL海關趨嚴輸歐備戰","newsDate":"2026/09/10","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1789337207048},"relatedStocks":"7912,7917","sourceUrl":"https://packagingeurope.com/news/sealed-aluminium-foil-excluded-from-eus-tethered-lid-requirements/14711.article","updatedAt":1789337206748,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789337206748,"event":"歐盟網路韌性法案 CRA 申報要求 2026/9/11 生效，所有聯網產品含聯網醫材均須行動","id":"3e5ef718915beb287d60841d","impact":"聯網醫材新增網安申報義務；與 MDR 併行合規，短線增加法遵成本，長線利好頭部廠商護城河","itemType":"MEDICAL_NEWS","name":"法規歐盟CRA申報911生效 聯網醫材須申報","newsDate":"2026/09/11","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1789337206948},"relatedStocks":"MDT,GETI-B","sourceUrl":"https://www.taylorwessing.com/en/insights-and-events/insights/2026/09/cra-reporting-requirements","updatedAt":1789337206748,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789337206748,"event":"Kaplan Fox 等律所公告調查 Medline 證券法違規，FDA 警告信後股價暴跌觸發，徵集投資人","id":"26e4e79a7a31d5d14eb4145c","impact":"MDLN 面臨集體訴訟風險，若立案估值壓制延續；追蹤 MDLN 回應與 FDA 整改令","itemType":"MEDICAL_NEWS","name":"法規MDLN證券調查 Kaplan Fox徵集投資人","newsDate":"2026/09/11","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1789337207148},"relatedStocks":"MDLN","sourceUrl":"https://natlawreview.com/press-releases/kaplan-fox-investigating-medline-inc-nasdaq-mdln-possible-securities-law","updatedAt":1789337206748,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789337206748,"event":"A\u0026O Shearman 發布 PPWR 跨國企業合規指引；Z2Data 整理趕工製造商快速合規路徑：基線申報、EPR 註冊、海關查驗三步驟","id":"51256dac471ba395e83f4d32","impact":"PPWR 生效第二個月執法觀察期，首要完成基線申報與 EPR 註冊；追蹤首例海關攔查與確效成本","itemType":"MEDICAL_NEWS","name":"法規PPWR合規指引 基線申報EPR註冊海關查驗","newsDate":"2026/09/08","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1789337206848},"relatedStocks":"FRE,DIM.PA,GETI-B","sourceUrl":"https://www.aoshearman.com/en/insights/eu-packaging-and-packaging-waste-regulation-what-international-corporate-groups-should-know","updatedAt":1789337206748,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789337206748,"event":"美國 PACK Act 通過關鍵程序關卡，生產者延伸責任包裝立法加速；對醫療包裝合規路徑的潛在影響受關注","id":"58e9f2fefa9043564e6f4d0d","impact":"美版包裝生產者責任制若落地，醫療滅菌包裝追溯與申報負擔加重；與 EU PPWR 形成雙重合規，利好確效服務","itemType":"MEDICAL_NEWS","name":"法規美PACK Act闖關 生產者責任制逼近醫療包裝","newsDate":"2026/09/05","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1789337206748},"relatedStocks":"MDLN,CAH,DD","sourceUrl":"https://www.packagingdigest.com/regulations-standards/the-pack-act-clears-key-hurdle","updatedAt":1789337206748,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789337206748,"event":"MDDI 報 Boston Scientific 召回凸顯 FDA 對植入物包裝追溯從嚴；美醫療器材包裝報告點名 FDA 包裝確效為市場核心壁壘","id":"6c3f762ce0b3467915c252a0","impact":"FDA 召回加包裝確效雙主線：短線利空植入物廠、長線利好 ISO 11607 確效完整的日美包材龍頭；QMSR 倒數追蹤 NMPA 新 QMS 連動","itemType":"MEDICAL_NEWS","name":"法規FDA召回從嚴包裝確效壁壘 植入物追溯升級","newsDate":"2026/09/10","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1789337207248},"relatedStocks":"DD,7912,MDT","sourceUrl":"https://www.openpr.com/news/4627481/united-states-medical-device-packaging-market-2026-growth","updatedAt":1789337206748,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789337199473,"event":"Medtronic 在 Wells Fargo 醫療大會表示成長動能擴散至多事業部；市場點評 Cornerstone 加 Pi-Cardia 兩筆交易重塑投資邏輯","id":"b1e3c37c5f80aecbbbe24150","impact":"MDT 多事業部復甦敘事強化，上調後關注 Hugo 落地兌現；器械巨頭合作升溫或帶動歐系標的估值錨","itemType":"MEDICAL_NEWS","name":"MDT Wells Fargo大會成長擴散 重估機器人押注","newsDate":"2026/09/08","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789337199773},"relatedStocks":"MDT,SNN,DIM.PA","sourceUrl":"https://www.investing.com/news/transcripts/medtronic-at-wells-fargo-healthcare-conference-growth-broadens-93CH-4892141","updatedAt":1789337199473,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789337199473,"event":"Fortune BI：熱成型醫療包裝至 2034 規模展望更新；托盤泡罩需求與手術量復甦連動","id":"b272ddcda995e90fdc79ff96","impact":"硬質托盤加蓋材需求穩定，利好托盤廠與 DNP 成型鏈；手術量復甦為 CAH、STE 耗材分銷的量價支撐","itemType":"MEDICAL_NEWS","name":"熱成型醫療包裝至2034展望 托盤跟手術量走","newsDate":"2026/09/08","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789337199573},"relatedStocks":"CAH,STE","sourceUrl":"https://www.fortunebusinessinsights.com/thermoformed-medical-packaging-market-118365","updatedAt":1789337199473,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789337199473,"event":"Benchmark 在泰國以工程深度推動高混合製造成長；泰電子投資破 300 億美元進軍晶片與 AI，EEC 聚落外溢至醫材精密製造","id":"3072504307d44246bc0564e5","impact":"泰國高混合製造加 BOI 優惠吸引醫材代工轉移；Medtecs 等東南亞鏈受惠轉單","itemType":"MEDICAL_NEWS","name":"Benchmark加碼泰國高混合製造 醫材代工轉移","newsDate":"2026/09/05","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789337199873},"relatedStocks":"546.SI","sourceUrl":"https://www.eetasia.com/benchmark-leverages-engineering-depth-to-drive-high-mix-manufacturing-growth-in-thailand/","updatedAt":1789337199473,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789337199473,"event":"DuPont Q1 2026 法說重申 Tyvek 醫療包裝需求穩健；中國低值耗材集採後以量補價格局延續","id":"879327d6a809f767de2b331d","impact":"Tyvek 醫療鏈需求背書 DD 論述，DD 週跌為情緒性回調；中國低值耗材集採壓價但放量，滅菌包裝環節相對受惠","itemType":"MEDICAL_NEWS","name":"DD Tyvek醫療需求穩健 中國低值耗材以量補價","newsDate":"2026/09/10","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789337199973},"relatedStocks":"DD","sourceUrl":"https://fortune.com/company/dow-chemical/earnings/q1-2026/","updatedAt":1789337199473,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789337199473,"event":"機構 13F 動態：Wellington 新建倉 MDLN 247 萬美元、Baird 加碼 34.9 萬股；反面 H\u0026F 減持 1559 萬股","id":"7539e3eca6870ab5429c379d","impact":"MDLN 籌碼多空分歧：長線機構逢低布局 vs PE 大股東退出；短線波動放大","itemType":"MEDICAL_NEWS","name":"MDLN機構籌碼分歧 Wellington建倉vsHF減持","newsDate":"2026/09/13","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789337199673},"relatedStocks":"MDLN","sourceUrl":"https://www.marketbeat.com/instant-alerts/filing-winton-group-ltd-boosts-stock-position-in-medline-mdln-2026-09-10/","updatedAt":1789337199473,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789337199473,"event":"IndexBox：無菌橡膠塞受生物製劑擴產帶動至 2035 高個位數 CAGR；全球次世代手術機器人至 2034 年 CAGR 約 15%","id":"d4deb8cd68576a8fcbb151f3","impact":"生物製劑加手術機器人雙引擎拉動無菌包材需求；利好 Sartorius、Getinge 滅菌設備鏈與 Terumo 注射劑包材","itemType":"MEDICAL_NEWS","name":"無菌橡膠塞加手術機器人雙成長 機器人CAGR15%","newsDate":"2026/09/12","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789337199473},"relatedStocks":"DIM.PA,GETI-B,4543","sourceUrl":"https://www.globenewswire.com/news-release/2026/09/09/3358972/0/en/global-next-generation-surgical-robotics-market-to-observe-impressive-growth-at-a-cagr-of-15-by-2034-delveinsight.html","updatedAt":1789337199473,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789337192205,"event":"IndexBox：透氣阻隔層壓材料受醫療感控與工業安全標準拉動加速成長；無菌袋膜至 2035 年展望正面","id":"d4fbc51ac458de6d1a1cccab","impact":"透氣蓋材與無菌袋膜需求與滅菌包裝擴張同頻；佐證滅菌包裝成長論述，利好 DD、DNP、Zacros 鏈","itemType":"MEDICAL_NEWS","name":"透氣阻隔層壓材加無菌袋膜需求加速 IndexBox","newsDate":"2026/09/13","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789337192605},"relatedStocks":"DD,7912,7917","sourceUrl":"https://www.indexbox.io/blog/breathable-barrier-laminates-market-forecast-to-2035-demand-accelerates-on-healthcare-infection-control-and-industrial-safety-standards/","updatedAt":1789337192205,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789337192205,"event":"泰國政府目標吸引逾 680 億銖醫療投資，並計畫與 MSD 簽約擴大臨床試驗；SUBCON 展零組件貿易達 7.05 億美元","id":"4675850c3e29606d92171446","impact":"泰國 BOI 加 EEC 醫療聚落成形；供應鏈轉移延續，利好在泰布局滅菌包材廠，追蹤 Thai FDA 與 AMDD 進度","itemType":"MEDICAL_NEWS","name":"泰國拚680億銖醫療投資 MSD臨床試驗","newsDate":"2026/09/11","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789337192705},"relatedStocks":"546.SI","sourceUrl":"https://www.nationthailand.com/health-wellness/40070812","updatedAt":1789337192205,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789337192205,"event":"Medtronic 宣布與 Cornerstone Robotics 戰略合作並投資 7 億美元擴大手術機器人全球可及性；Q1 FY2027 財報強勁上調全年展望","id":"578ef6f1b43b87d037c01fa3","impact":"MDT 9/11 收 90.96隨大盤回調，但 Hugo 落地加 Q1 上調構成中線支撐；機器人賽道加碼利好滅菌包材與手術耗材鏈","itemType":"MEDICAL_NEWS","name":"MDT 豪擲7億結盟Cornerstone＋Q1上調展望","newsDate":"2026/09/08","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789337192305},"relatedStocks":"MDT","sourceUrl":"https://www.medtechdive.com/news/medtronic-invests-700m-in-cornerstone-robotics/829354/","updatedAt":1789337192205,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789337192205,"event":"Boston Scientific 因 1081 起受傷事件召回脊髓刺激導線，為近期最大規模神經調控類召回","id":"a5fc17aac43d15e0af04eae3","impact":"召回升級或引發 FDA 對植入級包裝確效與追溯趨嚴；利好滅菌包裝確效服務與 ISO 11607 合規供應商","itemType":"MEDICAL_NEWS","name":"Boston Scientific 脊髓刺激導線召回 1081起受傷","newsDate":"2026/09/05","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789337192405},"relatedStocks":"MDT,SNN","sourceUrl":"https://www.mddionline.com/neurological/1-081-injuries-prompt-boston-scientific-to-recall-spinal-cord-stimulation-leads","updatedAt":1789337192205,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789337192205,"event":"Medline（MDLN）遭 FDA 警告信點名製造違規後，Kaplan Fox 等律所啟動證券法調查，股價單週重挫約 11%，9/10 觸及 12 個月新低 32.39，9/11 收 32.53","id":"344ffdcc230a3e44592223ca","impact":"MDLN 單週 -11.1% 為全族群最弱；FDA 警告信加證券調查雙重利空，機構逢低加碼但大股東減持，後續看整改與訴訟進展","itemType":"MEDICAL_NEWS","name":"MDLN 遭 FDA 警告信加證券調查 單週崩跌11%觸年低","newsDate":"2026/09/10","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789337192205},"relatedStocks":"MDLN","sourceUrl":"https://www.marketbeat.com/instant-alerts/price-medline-nasdaq-mdln-sets-new-12-month-low-should-you-sell-2026-09-10/","updatedAt":1789337192205,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1789337192205,"event":"美國醫療器材包裝市場報告：FDA 包裝合規驅動下持續擴張；醫療軟包裝與熱成型包裝至 2034 年維持高個位數成長","id":"477f83f959a54b82e1e33a44","impact":"滅菌包裝賽道需求能見度延續；利好 DuPont Tyvek、DNP、Zacros；FDA 包裝確效為核心進入壁壘","itemType":"MEDICAL_NEWS","name":"美醫療器材包裝展望 FDA合規驅動至2034成長","newsDate":"2026/09/10","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1789337192505},"relatedStocks":"DD,7912,7917","sourceUrl":"https://www.openpr.com/news/4627085/u-s-medical-device-packaging-market-2033-fda-packaging","updatedAt":1789337192205,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788732396803,"event":"CMDE 7/21發布57項註冊審查指導原則；NMPA 11/1新版QMS即將施行，滅菌隧道設備CAGR 7.5%；馬來西亞MDA 8/17發布追溯指令、BERNAMA點名中馬醫材監管合作","id":"d02417df820586a8176e03a3","impact":"中馬法規同步收緊，飛檢+追溯（UDI）為2026下半年主軸；滅菌設備與包材確效需求同步放大","itemType":"MEDICAL_NEWS","name":"NMPA 57項新指引+11/1新QMS倒數 — 馬來西亞UDI追溯跟進","newsDate":"2026/08/26","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1788732397303},"relatedStocks":"3407,8086,546.SI","updatedAt":1788732396803,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788732396803,"event":"PPWR 8/12起分階段適用：首階段為基線申報（完整包裝組合盤點+DoC），已上市包裝可續售不需下架；Healthcare Packaging 8/27專欄提醒醫療包裝需備妥單一材質/可回收證明，醫材豁免有限","id":"8a1dcf0fe27a7f12c8aa277b","impact":"PPWR進入執法觀察期，歐洲醫材包材（Sartorius、Fresenius、Getinge供應鏈）合規成本升；追蹤海關抽查首例與CPP/PE單一材質確效成本","itemType":"MEDICAL_NEWS","name":"PPWR首月執法觀察 — 8/12基線申報啟動、醫療包裝合規專欄示警","newsDate":"2026/08/27","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1788732396803},"relatedStocks":"DIM.PA,FRE,GETI-B","sourceUrl":"https://www.healthcarepackaging.com/industries/pharmaceuticals/article/22972327/healthcare-plastics-recycling-council-column-preparing-healthcare-packaging-for-ppwr-compliance","updatedAt":1788732396803,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788732396803,"event":"FDA 9月初明確定調：依現有科學研究，無理由限制含氟聚合物在醫材的持續使用；另發布醫材附件分類指引草案，10/16前徵求意見","id":"bc624756526afe89f2357a93","impact":"PFAS豁免明朗化，Tyvek/PTFE/氟聚合物包材與植入物供應鏈鬆一口氣；DD/STE/Gore系受惠","itemType":"MEDICAL_NEWS","name":"FDA定調PFAS醫材可用 — 含氟聚合物無使用限制、附件分類徵求意見至10/16","newsDate":"2026/09/01","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1788732397003},"relatedStocks":"DD,STE,MDT","sourceUrl":"https://www.fda.gov/medical-devices/products-and-medical-procedures/pfas-medical-devices-what-you-need-know","updatedAt":1788732396803,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788732396803,"event":"FDA 9/3 Packaging Digest：2026 Q1四起醫材召回與包裝/滅菌缺失相關（潛在非無菌、包裝不足、IFU缺失）；8/26 Becker's：FDA點名五起Class I召回（呼吸器/植入物/麻醉/透析）+ Cardinal無菌手術托盤Lot 2024-C/D潛在非無菌","id":"99f530d3ee37681f3ee92fb9","impact":"包裝完整性=召回重災區，ISO 11607確效與SPMC worst-case要求再強化；CAH托盤事件追蹤後續","itemType":"MEDICAL_NEWS","name":"FDA包裝召回示警 — Q1四起滅菌/包裝缺失、五起Class I含呼吸器植入物","newsDate":"2026/09/03","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1788732396903},"relatedStocks":"CAH,STE,MDLN","sourceUrl":"https://www.packagingdigest.com/pharma-medical/fda-recalls-highlight-packaging-mishaps-in-q1-2026","updatedAt":1788732396803,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788732396803,"event":"ISO 20417:2026（製造商提供資訊）獲FDA認可Rec# 5-149，DoC可沿用舊版Rec# 5-135至2029/7/1；9/9生物相容性Town Hall、9/10學名藥現代化會議接續登場","id":"642b45d983250820105e926d","impact":"標示/IFU過渡期長達近3年，包材印刷與滅菌標示改版壓力緩解；無菌包裝標示不合規仍為查核重點","itemType":"MEDICAL_NEWS","name":"ISO 20417:2026獲FDA認可 — DoC過渡至2029/7/1、標示改版壓力緩","newsDate":"2026/09/01","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1788732397103},"relatedStocks":"STE,MDLN,CAH","sourceUrl":"https://meddeviceguide.com/blog/iso-20417-2026-information-supplied-manufacturer-fda-recognition-guide","updatedAt":1788732396803,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788732396803,"event":"MDDI 9/4專文：FDA 2026年AI醫材監管現實——律師拆解合規路徑與後續立法方向；QMSR距全面適用僅數月，投訴/CAPA/風險盲點為查核重點","id":"87cbf72ae9aab01a3c28d666","impact":"AI醫材+QMSR雙線收緊，MDT/SNN等智慧醫材廠商確效成本升；警告信後續為下一棒追蹤點","itemType":"MEDICAL_NEWS","name":"FDA AI醫材監管專文 — 2026合規現實+QMSR查核倒數","newsDate":"2026/09/04","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1788732397203},"relatedStocks":"MDT,SNN","sourceUrl":"https://www.mddionline.com/artificial-intelligence/fda-ai-medical-device-guidelines-2026-expert-legal-perspective-on-compliance","updatedAt":1788732396803,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788732378043,"event":"Medtronic FY27 Q1 營收 $9.76B 年增13.7%超預期，有機成長上調至7.25-7.75%、non-GAAP EPS上調至$5.94-6.00，財報後股價連漲四日至$94.17（vs 8/28 +3.22%）","id":"fb877e3ca946605377e93167","impact":"MDT財報beat+上調全年指引，短線動能轉強；滅菌器系統銷售年增60%亦佐證滅菌包材需求旺","itemType":"MEDICAL_NEWS","name":"Medtronic FY27 Q1大勝上調全年 — 營收$9.76B +13.7%、9/1財報後連漲","newsDate":"2026/09/01","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788732378043},"relatedStocks":"MDT","sourceUrl":"https://news.medtronic.com/2026-09-01-Medtronic-reports-first-quarter-fiscal-2027-results-delivers-broad-based-portfolio-performance-and-raises-fiscal-2027-guidance","updatedAt":1788732378043,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788732378043,"event":"中國VBP持續擴圍：高值耗材集採常態化，第12批藥品65品種 + 第11輪初步中選公布；省際聯盟加速，骨科植入降價50-80%前例，低值耗材/根管耗材價格承壓、經銷商毛利壓縮","id":"256cae0069f12b427faa1dac","impact":"集採刀鋒向低值耗材/滅菌包裝延伸，中國本土包材廠（威高、穩健）以價換量，外資需靠高階滅菌確效差異化突圍","itemType":"MEDICAL_NEWS","name":"中國集採擴圍低值耗材 — 第12批65品種、滅菌包材以價換量壓力升","newsDate":"2026/08/24","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788732378943},"relatedStocks":"3407,8086,4543.T","updatedAt":1788732378043,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788732378043,"event":"美國無菌醫材包裝市場2025年$6.37B，預計2035年達$15B、CAGR 8.94%；藥品fill-finish市場2026 $19.75B→2031 $30.37B帶動新投資","id":"250443e78758ab570e3a5312","impact":"美國本土滅菌包裝需求強勁，MDLN/CAH/STE供應鏈在地化受惠；fill-finish擴產連動無菌包材拉貨","itemType":"MEDICAL_NEWS","name":"美國無菌包裝$6.37B→$15B — CAGR近9%、fill-finish擴產連動","newsDate":"2026/09/02","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788732378743},"relatedStocks":"MDLN,CAH,STE","sourceUrl":"https://www.packagingdigest.com/pharma-medical/pharma-fill-finish-growth-spurs-new-investments","updatedAt":1788732378043,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788732378043,"event":"Accendra Health 9/5提交8-K：董事會延續CEO繼任程序，預計9月中前宣布Dan Pesicka繼任者；Baird 8/11已降評至Neutral、目標價$6→$1.50","id":"49ee9ca505241e00bc95bde7","impact":"ACH换帅在即為短線變數，$1.2附近磨底；若新CEO來自大型經銷商有望重振信心，否則Nasdaq $1合規風險續存","itemType":"MEDICAL_NEWS","name":"Accendra Health 9月中前宣布新CEO — 8-K繼任程序+ Baird降評追蹤","newsDate":"2026/09/05","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788732378543},"relatedStocks":"ACH","sourceUrl":"https://www.stocktitan.net/sec-filings/ACH/8-k.html","updatedAt":1788732378043,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788732378043,"event":"滅菌醫材包裝市場2026年約$6.2B，預計2033年達$16.2B、CAGR 14.5%；無菌屏障包裝2026-2034 CAGR 5.27%；滅菌包布市場2026-2035 CAGR 3.88%","id":"b5fef5a0c00eb5bb7aeea3cf","impact":"滅菌包裝賽道雙位數成長，Tyvek/無紡布/滅菌袋供應鏈（Zacros、明基材、Medtecs）直接受惠","itemType":"MEDICAL_NEWS","name":"滅菌醫材包裝市場爆發 — 2026 $6.2B→2033 $16.2B、CAGR 14.5%","newsDate":"2026/09/03","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788732378643},"relatedStocks":"DD,7917,8215,546.SI","sourceUrl":"https://www.linkedin.com/pulse/sterilization-medical-packaging-market-size-analysis-growing-uk8ge","updatedAt":1788732378043,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788732378043,"event":"STERIS 9/1起連四黑，9/4再跌0.99%至$224.59，vs 8/28累跌3.93%為本週最弱美股，跌破230關口","id":"74cc220ba72ab0d38ceb5422","impact":"STE短線破線轉弱，滅菌服務需求無虞但評價修正；留意是否為族群資金輪動至MDT/CAH","itemType":"MEDICAL_NEWS","name":"STERIS連四黑跌破230 — 9/4收$224.59、本週最弱美股","newsDate":"2026/09/04","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788732378343},"relatedStocks":"STE","updatedAt":1788732378043,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788732378043,"event":"Medline 9/4持平$36.59，9/2跳漲至$36.30後高檔橫盤，vs 8/28再漲3.71%，IPO以來累漲逾35%續處新高區","id":"f317c665574535bab694f04d","impact":"MDLN高檔量縮橫盤，追高風險升但趨勢未壞；滅菌手術服/鋪單龍頭續受機構青睞","itemType":"MEDICAL_NEWS","name":"Medline高檔橫盤續創高 — 9/4持平$36.59、vs 8/28再漲3.7%","newsDate":"2026/09/04","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788732378143},"relatedStocks":"MDLN","updatedAt":1788732378043,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788732378043,"event":"Medtec China 2026：NMPA通報初始/延續/變更註冊批准達14,187件；2026醫材製造五大趨勢為更智慧、更精準、更合規、更彈性、更高效，包裝/滅菌/潔淨室為八大焦點之一","id":"003cb8bf3f19236d5d2828a6","impact":"中國醫材准入放量，滅菌包裝/潔淨室設備需求旺；台日包材廠（明基材、Zacros）中國轉單機會增","itemType":"MEDICAL_NEWS","name":"Medtec China 2026 — NMPA年批14,187件、包裝滅菌列製造焦點","newsDate":"2026/08/25","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788732378843},"relatedStocks":"8215,7917,3407","sourceUrl":"https://en.medtecchina.com/media/show/medtec-china-2026-top-medical-device-manufacturing-trends/","updatedAt":1788732378043,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788732378043,"event":"DuPont 9/4小漲0.35%至$131.59，8/31起連跌後暫止穩守住131，vs 8/28累跌3.94%；Tyvek醫材包裝需求仍穩","id":"3b1eced386573616fcc25cf9","impact":"DD止跌但反彈乏力，Tyvek替代關注Dawnsens進度；131為短線防守位","itemType":"MEDICAL_NEWS","name":"DuPont止穩131 — 9/4小漲0.35%收$131.59、連跌後暫歇","newsDate":"2026/09/04","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788732378443},"relatedStocks":"DD","updatedAt":1788732378043,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788732378043,"event":"Cardinal Health 9/4收$247.18（-0.58%），但vs 8/28大漲5.39%為本週最強美股；HME News 9月刊點名Cardinal加碼CGM與泌尿產品線","id":"02ed4fd6f9cb05ff20624d1a","impact":"CAH連漲四日後小回，CGM/泌尿新動能+VA MSPV Gen-Z集採題材支撐，趨勢仍強","itemType":"MEDICAL_NEWS","name":"Cardinal Health本週+5.4%最強 — 加碼CGM/泌尿、9/4小回$247.18","newsDate":"2026/09/04","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788732378243},"relatedStocks":"CAH","sourceUrl":"https://digital.hmenews.com/september-2026/page-1?p=3","updatedAt":1788732378043,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788732378043,"event":"泰國BOI 2026上半年：醫療健康為中泰合作強項；EEC累計投資目標2.2兆泰銖橫跨醫療/數位/電子；THECA 2026推BOI本地供應鏈平台連結國際醫材廠與泰國供應商；BDMS 2026學術年會鞏固ASEAN醫材龍頭地位","id":"7add770a0827f0d21f31276c","impact":"泰國醫療聚落吸金，滅菌包材/手套在地供應鏈成形；Medtecs等東南亞廠BOI優惠+AMDD調和紅利","itemType":"MEDICAL_NEWS","name":"泰國醫療聚落吸金 — BOI上半年亮眼、EEC 2.2兆泰銖+本地供應鏈平台","newsDate":"2026/08/27","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788732379043},"relatedStocks":"546.SI","updatedAt":1788732378043,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788732378043,"event":"日股醫療分化：Nipro -3.8%、Terumo -4.2%領跌，Asahi -0.2%小跌，DNP -1.2%，Zacros -2.2%相對抗跌；背景為TOPIX 8月+3.8%五連漲、日經+3.0%，9月初大幅震盪","id":"e5bea2257927f6afd1decd9e","impact":"日股醫療跑輸大盤，資金輪動至AI/半導體；Zacros相對強勢可續追蹤，Nipro跌破1500後觀察止穩","itemType":"MEDICAL_NEWS","name":"日股醫療跑輸大盤 — Nipro/Terumo領跌、Zacros相對抗跌","newsDate":"2026/09/04","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788732379143},"relatedStocks":"8086,4543.T,7917,3407,7912","updatedAt":1788732378043,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788127746996,"event":"日股醫療包材 8/28 分化：Asahi Kasei 3407 ¥1,615.5 -2.03%、Nipro 8086 ¥1,528 -0.26%、DNP 7912 ¥3,093 -0.29% 回檔，Zacros 7917 ¥1,280 +1.03% 逆勢收紅、Terumo 4543 ¥2,539 -0.82%。日經醫療板塊量能平穩，外資對高位包材股獲利了結。","id":"4012a7a66644bc5cb6016389","impact":"板塊高檔分化，資金輪動至相對低位標的。Zacros 相對抗跌顯示中小盤包材股估值吸引力；3407、7912 回檔為正常整理，不改長線 PPWR 與無菌需求支撐。","itemType":"MEDICAL_NEWS","name":"日本醫療包材股 8/28 分化 — 旭化成 -2.03%、Nipro -0.26%、Zacros +1.03%","newsDate":"2026/08/28","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788127748096},"relatedStocks":"3407,7912,7917,8086,4543","sourceUrl":"https://query1.finance.yahoo.com/v8/finance/chart/3407.T","updatedAt":1788127746996,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788127746996,"event":"DuPont (DD) 8/28 收 $136.98（138.80→136.98 -1.31%），較 8/21 138.33 -0.98% 高檔整理；盤中高 $141.00、低 $135.83、量105萬。Tyvek 非織造布報價持平，PPWR 可回收包材替代趨勢下 DuPont 推永續 Tyvek 獎。","id":"71c56f616b54ca3fb949cfe4","impact":"Tyvek 供給平穩有利成本可控，但 PPWR 單一材質趨勢對 Tyvek 長期構成替代壓力。短線股價隨大盤整理，中長線需觀察 Tyvek 永續化進度。","itemType":"MEDICAL_NEWS","name":"DuPont 8/28 回檔 -1.31% 至 $136.98 — Tyvek 原料鏈高檔震盪","newsDate":"2026/08/28","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788127747296},"relatedStocks":"DD,7912,3407","sourceUrl":"https://api.nasdaq.com/api/quote/DD/historical","updatedAt":1788127746996,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"_postedAt":1787307197940,"_postedAtSource":"threads-shortcode","createdAt":1788127746996,"event":"Dawnsens 8/27 發表 Flash-spun 不織布（類 Tyvek 技術路徑）無菌屏障材料，宣稱在多種滅菌方式（EO、伽馬、蒸汽）下保持完整性，瞄準醫療包裝 Tyvek 替代市場。","id":"8ea1b227cac2ddf6ae5c3677","impact":"Tyvek 替代競品增加，PPWR 與成本壓力下醫療包材多元化加速。對 DuPont Tyvek 構成中長期競爭壓力；對採用方可降低單一供應商風險、議價力提升。","itemType":"MEDICAL_NEWS","name":"Dawnsens Flash-spun 不織布新品 — 無菌屏障材料創新","newsDate":"2026/08/27","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788127747996},"relatedStocks":"DD,7917,3407","sourceUrl":"https://www.instagram.com/p/DcTGLcNiXzU/","updatedAt":1788127746996,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788127746996,"event":"馬來西亞醫療器材管理局 (MDA) 8/17 發布植入器械追溯中期指令，要求強化 UDI 與全鏈條追溯；Andaman Medical 同期指出 ASEAN 各國正加速 AMDD 落地，馬來西亞與泰國為先行者。","id":"4e760453db20951af8c1e1ab","impact":"ASEAN 追溯與 UDI 要求趨嚴，醫療包材需強化標籤與數據載體（GS1/UDI）相容，短期增加 IT 與包材改版成本，長期有利具追溯系統能力的規模廠。利好 DNP、Terumo 等具 ASEAN 合規經驗者。","itemType":"MEDICAL_NEWS","name":"馬來西亞 MDA 植入器械追溯中期指令 8/17 — ASEAN 器械監管趨嚴","newsDate":"2026/08/17","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788127747896},"relatedStocks":"7912,4543,546.SI","sourceUrl":"https://andamanmed.com/regulatory-updates/","updatedAt":1788127746996,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788127746996,"event":"Medline (MDLN) 8/28 收 $35.28（Nasdaq 歷史 $35.28 vs Yahoo 34.65），日內高 $35.77、低 $34.60、量571萬，較 8/21 $34.26 +2.98%，IPO 來累計+35%。Nasdaq 歷史表顯示 8/28 為本週高點，8/20 低點 $32.58 後 V 型反彈。","id":"6091bf5b4a04ba21a0cce235","impact":"IPO 後籌碼換手充分，醫療耗材龍頭維持多頭。對 CAH、MDT 有比價效應；需留意 8/28 高檔量縮（571萬 vs 8/27 787萬），短線追價風險。","itemType":"MEDICAL_NEWS","name":"Medline 8/28 續強 +1.82% 至 $35.28 — Nasdaq 歷史數據確認收盤","newsDate":"2026/08/28","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788127747096},"relatedStocks":"MDLN","sourceUrl":"https://api.nasdaq.com/api/quote/MDLN/historical","updatedAt":1788127746996,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788127746996,"event":"Sartorius Stedim Biotech (DIM.PA) 8/28 regularMarketPrice €197.70（196.70→197.70 +0.51%），較 8/21 193.50 +2.17% 本週歐股最強；一次生物製程包材/過濾需求穩健。Carl Zeiss Meditec 同期 Q3 營收 €437.6M 持平（外匯調整後），FY24/25 指引維持。","id":"688aa5687c74e626899e512c","impact":"歐洲生物製程包材鏈相對抗跌，驗證高值耗材需求韌性。對 Fresenius、Getinge 有比價支撐；需追蹤歐洲醫院資本支出回溫時點。","itemType":"MEDICAL_NEWS","name":"Sartorius Stedim 8/28 +0.51% 至 €197.70 — 歐股醫材相對抗跌","newsDate":"2026/08/28","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788127747796},"relatedStocks":"DIM.PA,FRE,GETI-B","sourceUrl":"https://query1.finance.yahoo.com/v8/finance/chart/DIM.PA","updatedAt":1788127746996,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788127746996,"event":"OpenPR 8/20 報告：全球醫療器材包裝市場 2025 $44.12B 預計 2033 達 $101.90B CAGR 11.7%；滅菌醫療包裝 2026 $3.44B→2035 $7.09B，無菌屏障系統 CAGR 8.8%。不織布市場 2025 $54.0B→2036 $85.8B CAGR 4.3%；熔噴 PP 纖維 2026 $1.29B。","id":"d067cfe6ba8fa8d21ef89abd","impact":"板塊級長線正向催化，驗證醫療包材為結構性成長賽道。對 DNP、Zacros、3407、DD 為估值支撐；PP 原料與不織布產能為關鍵瓶頸，需追蹤原料價差。","itemType":"MEDICAL_NEWS","name":"醫材包裝市場 $44.12B→$101.90B CAGR 11.7% — 板塊級長線動能確認","newsDate":"2026/08/20","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788127747396},"relatedStocks":"7912,3407,7917,DD","sourceUrl":"https://www.openpr.com/news/4609363/medical-device-packaging-market-to-reach-us-101-90-billion","updatedAt":1788127746996,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788127746996,"event":"明基材 (8215) 8/28 收 NT$26.20（Yahoo 24.85→26.20 +5.43%），較 8/21 23.95 +9.39% 本週漲幅第一。台股醫療包材鏈中，隔離膜/偏光膜轉型醫療應用題材發酵，成交量放大，外資回補。","id":"5f12b6ac33146a8fdebf03f8","impact":"台廠醫療包材轉型獲資金認可，對 8215 為直接利多；族群上帶動亞洲包材股情緒，但需確認 Q2 財報是否支撐續航，避免題材一日行情。","itemType":"MEDICAL_NEWS","name":"明基材 8/28 爆量 +5.43% 至 NT$26.20 — 本週最強、醫療包材台廠領漲","newsDate":"2026/08/28","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788127747196},"relatedStocks":"8215","sourceUrl":"https://query1.finance.yahoo.com/v8/finance/chart/8215.TW","updatedAt":1788127746996,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788127746996,"event":"Medtronic 8/19 公布 Q1 FY26：營收 $9.81B（beat 共識 $9.8B）、non-GAAP EPS $1.55（beat $1.54），心血管/神經科學/糖尿病三引擎齊增；全年有機成長指引由 5% 上調至約 5.5%（含匯率 4.8-5.1%），股價 8/28 +1.40% 至 $91.23（8/21 $93.35→8/28 反彈，量646萬），9/01 後累計+23%站上 $92。","id":"3aa7d4e3c007f58b6bb84c81","impact":"醫材龍頭財報利多支撐族群情緒，對供應鏈（滅菌包材、導管耗材）拉貨為正向。QMSR PCCP 框架下 Hugo 機器人迭代加速，利好精密包材與滅菌服務需求。維持族群龍頭溢價。","itemType":"MEDICAL_NEWS","name":"Medtronic Q1 FY26 擊敗共識 — 營收 $9.81B、EPS $1.55，上調全年成長至 5.5%","newsDate":"2026/08/19","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788127746996},"relatedStocks":"MDT,STE","sourceUrl":"https://seekingalpha.com/article/4938788-medtronic-expecting-strong-revenue-growth-in-fiscal-q1","updatedAt":1788127746996,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788127746996,"event":"Sterilization Packaging Manufacturers Council (SPMC) 8/20 更新 FAQ：ISO 11607 下 worst case 概念由固定式改為情境相依（context-dependent），滅菌、材料、幾何形狀組合決定最差條件；ISO 11607-1:2019 無菌屏障完整性須以氣泡逸散等物理測試驗證。Eurofins 同期舉辦 ISO 11607 封裝確效研討。","id":"32a70b308b6f2d7a45a69369","impact":"確效邏輯更靈活但文件化要求更高，醫療包材廠可依產品家族分組減少重複測試，但需更嚴謹的風險論證。利好具家族化管理能力的 DNP、Oliver Healthcare；小型廠確效負擔增加。","itemType":"MEDICAL_NEWS","name":"SPMC ISO 11607 FAQ 重磅更新 — worst case 重新定義為情境相依","newsDate":"2026/08/20","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788127747496},"relatedStocks":"7912,7917,DD","sourceUrl":"https://www.healthcarepackaging.com/design-materials/medical-device-packaging/article/22972323/sterilization-packaging-manufacturers-council-spmc-spmcs-updated-faq-resource-a-technical-reference-for-healthcare-packaging-decisions","updatedAt":1788127746996,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788127746996,"event":"IndexBox 8/25 報告：SMS（紡粘-熔噴-紡粘）保護性層壓材全球需求 2026-2035 年均 +4-6%，由醫療安全升級與工業防護服需求驅動；Straits 8/19 預估醫療服飾 2026 $115.4B→2034 $190.56B CAGR 6.47%，Cardinal/Medline 為前五大廠。Dawnsens 推出 Flash-spun 不織布無菌屏障材料。","id":"5246c09a4ab26dbbf84b77c8","impact":"SMS/不織布為滅菌包裝核心材料，需求穩增支撐 3407、7917 等原料廠稼動率；價格持穩有利毛利。中長線關注 PP 價差與 rPP 導入對成本結構影響。","itemType":"MEDICAL_NEWS","name":"不織布/SMS 保護性層壓材需求穩增 4-6% — 醫療安全升級驅動","newsDate":"2026/08/25","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788127747596},"relatedStocks":"3407,7917,MDLN,CAH","sourceUrl":"https://www.indexbox.io/blog/sms-protective-laminates-market-outlook-to-2035/","updatedAt":1788127746996,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788127746996,"event":"Cardinal Health (CAH) 8/28 收 $234.55（235.13→234.55 -0.25%），較 8/21 229.51 +2.20% 本週累計收紅；Nasdaq 歷史顯示 8/28 量177萬較 8/27 103萬放大，高 $236.80、低 $233.72。Q4 FY26 營收 $63.7B+6%、EPS $2.91 beat，FY27 指引+13-15% 仍為支撐。","id":"36370d05f7c75be13aaa1405","impact":"高檔整理不改多頭，經銷龍頭穩健。對醫療耗材供應鏈為正向訊號；需留意 8/28 量增價跌的短線調節壓力。","itemType":"MEDICAL_NEWS","name":"Cardinal Health 8/28 -0.25% 至 $234.55 — 高檔整理、FY27 指引支撐","newsDate":"2026/08/28","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1788127747696},"relatedStocks":"CAH,MDLN","sourceUrl":"https://api.nasdaq.com/api/quote/CAH/historical","updatedAt":1788127746996,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788127712357,"event":"歐盟包裝暨包裝廢棄物法規 PPWR（EU 2025/40）自 2026/08/12 全面適用首週：BCLP、Freyr 8/17-19 確認食品接觸包裝 PFAS 使用限制、SoC（高度關注物質）供應鏈申報即刻強制；JAS、GetReady 指出多數義務採分階段，首波為建立完整包裝組合基線數據並提供 DoC，海關抽查已啟動。Healthcare 包裝需文件化完整包裝組合（Healthcare Plastics Recycling Council 8/27 專欄）。","id":"f0896edcae4ff37afde552e9","impact":"醫療包材無完全豁免，immediate 包裝屬接觸敏感（Article 7）須同步符合 PPWR。未完成基線與 DoC 的輸歐廠面臨邊境扣留風險；PFAS 替代與可回收設計成為下半年投資主軸。對 DNP、Zacros、DuPont Tyvek 有中長期合規成本與商機雙重影響。","itemType":"MEDICAL_NEWS","name":"PPWR 8/12 全面適用首週執法動態 — PFAS/SoC 基線申報強制","newsDate":"2026/08/19","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1788127712357},"relatedStocks":"7912,7917,DD,3407","sourceUrl":"https://viamedici.com/blog/ppwr-pim-packaging-data/","updatedAt":1788127712357,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788127712357,"event":"中國 NMPA 8/14 公布 46 項醫療器械行業標準（含 YY 0055-2026 牙科光固化機等），11/01 新版《醫療器械生產質量管理規範》正式施行；Sterilization Equipment 市場報告提及 NMPA 修訂無菌要求為 48% 市占的滅菌器械板塊主要驅動，滅菌隧道市場 2025 $1.28B→2032 $2.12B CAGR 7.5%。","id":"d77e3da4a504faa1531c2c23","impact":"中國輸中包材/滅菌廠需在 11/1 前完成新 QMS 調和與 46 行標轉版；滅菌包材（EO/輻照相容）與隔離器需求隨合規升級而增。利好具中國落地能力的穩健醫療、威高等；對僅供原料的海外廠增加註冊成本。","itemType":"MEDICAL_NEWS","name":"NMPA 8/14 公布 46 項行標＋11/1 新版 QMS 施行倒數","newsDate":"2026/08/14","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1788127712757},"relatedStocks":"DD,3407","sourceUrl":"https://www.linkedin.com/posts/martink2_release-of-46-medical-device-industry-standards-activity-7495056869410062336-rQ4K","updatedAt":1788127712357,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788127712357,"event":"NMPA 公布行標同期，Strategic Market Research 8/21 指中國滅菌隧道市場受無菌藥品與醫材在地化驅動快速擴產；醫保「十五五」規劃（8/24）明確集采規則迭代與創新藥價格保護，質量監管對中標後飛檢「原始數據抽檢」加嚴，四家企業近期因集采清退出局。","id":"e173b2a6d79c2b196099dcea","impact":"中國 VBP 國產替代加速，不織布/薄膜包材本土產能擴張。中標廠需承擔更嚴無菌確效成本，利好具規模與驗證能力的頭部包材廠；低價搶標模式風險升高，間接利好日廠高品質包材出口轉單。","itemType":"MEDICAL_NEWS","name":"中國無菌包裝供應鏈 — 滅菌隧道擴產與集采質量監管強化","newsDate":"2026/08/21","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1788127712857},"relatedStocks":"7917,3407,DD","sourceUrl":"https://www.strategicmarketresearch.com/market-report/sterilization-tunnel-market","updatedAt":1788127712357,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788127712357,"event":"Lexology 8/21、Luther Lawfirm 8/25 披露：泰國 BOI 2026 新版指南（Announcement No. 6/2568）將醫療器材、高值健康產品列為國家投資戰略核心，提供 8 年免稅＋進口機械關稅豁免等，條件需併同 Thai FDA 與移民許可；BOI 上半年申請額達 1.47 兆泰銖，醫療為重點招商產業。","id":"dc80fee3059daae5164207b2","impact":"泰國成為 ASEAN 醫療包材/滅菌在地化熱點，吸引日歐廠轉移產能。對 DNP、Terumo、Fresenius 等已布局東南亞者有利；需留意 BOI 審批與 Thai FDA 雙軌時程，短期投資成本增加、長期關稅與供應鏈韌性受益。","itemType":"MEDICAL_NEWS","name":"泰國 BOI 2026 新版投資促進指南 — 醫療器材列國家戰略核心","newsDate":"2026/08/21","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1788127712957},"relatedStocks":"7912,4543,FRE","sourceUrl":"https://www.lexology.com/library/detail.aspx?g=4c1758a7-4ab0-4fee-80ef-c4780088f04c","updatedAt":1788127712357,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788127712357,"event":"CIRS 8/12 與台灣 MLS MDR 專文釐清：PPWR 對醫療器材 immediate 包裝無全面豁免，僅特定接觸敏感包裝適用物質限制特殊處理；任何因 PPWR 調整的包材變更（單一材質 CPP/PE、rPP）皆觸發 MDR 技術文件與 ISO 11607/滅菌確效重評，標籤可回收聲明須符合 EN 標準。","id":"810a7fbd5e944a933c3991a3","impact":"包材變更→需重做滅菌、加速老化、密封強度與無菌屏障測試，確效成本增加 3-6 個月時程。利好通過 ISCC PLUS、已布局單一材質方案的 DNP、Amcor；落後廠面臨 2027 EPR 費用激增。","itemType":"MEDICAL_NEWS","name":"PPWR 醫材豁免釐清 — CIRS/MLS MDR 確認 immediate 包裝無豁免、需重評 MDR/ISO 11607","newsDate":"2026/08/20","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1788127712457},"relatedStocks":"7912,DD,7917","sourceUrl":"https://mlsmdr.com.tw/en/article/1/7","updatedAt":1788127712357,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788127712357,"event":"FDA QMSR 自 2026/02/02 生效滿五個月：Medicept 8/25、PR Newswire 8/27 披露查核數據顯示，檢查員聚焦投訴處理（complaint handling）、CAPA 與 ISO 14971 風險管理銜接缺口；QSIT 已轉向 ISO 13485 思維，文件化「風險基礎決策」成為觀察項熱點。","id":"e7480e9595c0568c1a5a57d8","impact":"對輸美滅菌包材/醫材廠而言，QMSR 缺口=483 觀察項→警告信風險升高。需補強風險文件與供應商管制；利好已完成 ISO 13485 調和的 Medtronic、STERIS 等 QMS 成熟廠。短期稽核成本上升、長期有利品質體系接軌歐盟 MDR。","itemType":"MEDICAL_NEWS","name":"FDA QMSR 滿五個月查核實況 — 投訴/CAPA/風險管理成新盲點","newsDate":"2026/08/27","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1788127712557},"relatedStocks":"MDT,STE,MDLN","sourceUrl":"https://www.medicept.com/resources/blog/qmsr-five-months-fda-inspection-realities","updatedAt":1788127712357,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788127712357,"event":"MDD Online 8/24 專文指出 QMSR 將品質視為創新賦能：透過預定變更控制計畫（PCCP）允許核准後設計迭代，若文件化 6 元素（驗證、風險、可用性等）可走 90 天補充路徑，無需重提 510(k)。CDRH Learn 同步更新 QMSR 培訓模組。","id":"72db6be98f15879b0eb84dde","impact":"有利 Medtronic Hugo 機器人、微創器材快速迭代；包材廠若將 PPWR 驅動的材質替換納入 PCCP，可縮短重提時程。利好研發驅動的 MDT、DD；法規顧問需求增加。","itemType":"MEDICAL_NEWS","name":"FDA QMSR 創新框架 — PCCP 設計變更 6 元素與 90 天路徑","newsDate":"2026/08/24","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1788127712657},"relatedStocks":"MDT,DD","sourceUrl":"https://www.mddionline.com/regulatory-quality/innovation-under-qmsr-building-a-development-system-that-absorbs-change-without-sacrificing-control","updatedAt":1788127712357,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1788127712357,"event":"Veropharm Group 8/18、Elendilabs 專訪指出泰國循 ASEAN AMDD 四級分類（Class 1-4），Class 2-4 須提交 CSDT 技術文件；2026 Licensing Facilitation Act 簡化審批流程，註冊與測試費用同步更新，電子郵件線上提交。Thai FDA 與 ASEAN 互認磋商推進。","id":"7f494b1e4732529f0691a180","impact":"泰國取證週期縮短，利好計畫以泰國為 ASEAN 跳板的包材/醫材廠，CSDT 文件準備成為准入門檻。對 Medtecs、INTCO 等東南亞手套/包材廠為利多；短期法規顧問與翻譯成本增加。","itemType":"MEDICAL_NEWS","name":"泰國 Thai FDA AMDD 調和加速 — CSDT 技術文件分級與許可簡化","newsDate":"2026/08/18","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1788127713057},"relatedStocks":"546.SI,FRE","sourceUrl":"https://veropharmagroup.com/medical-devices/technical-file-csdt","updatedAt":1788127712357,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522886486,"event":"Coveris 收購 GEFO 擴 CPP 薄膜產能呼應 PPWR 單一材質趨勢；滅菌袋市場 CAGR 6.1%（單一材質 PE/CPP 替代 PA/PE 複合），DNP 等大廠推回收單一材質滅菌袋試量產，PPWR Article 7 接觸敏感包裝回收含量豁免路徑待 EC 細則。","id":"e16d82de47145c13e5682192","impact":"單一材質滅菌袋成為 PPWR 合規主流，但需重做 ISO 11607 密封與老化確效；先行取得數據的頭部廠（DNP/Zacros）搶佔 2026-27 換材窗口。","itemType":"MEDICAL_NEWS","name":"滅菌袋與單一材質升級 — CPP薄膜與回收含量路徑","newsDate":"2026/08/19","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1787522886886},"relatedStocks":"7912,7917,DD","updatedAt":1787522886486,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522886486,"event":"研究口徑：醫用不織布 2025 $30.39B→2031 $38.98B（CAGR 4.2%），滅菌裹材 CAGR 11.5%；醫材包裝材料 $43.5B→2033 $65.8B CAGR 6.1%；非織造衛生 $22.6B。亞太為最快增速區，中國與東南亞新增產能集中。","id":"7b83e3387c2a661fe78f053e","impact":"包材與不織布需求中長期向好，但 PPWR 與 QMSR 雙重認證門檻將加速份額向頭部集中，中小廠面臨價格與合規雙擠壓。","itemType":"MEDICAL_NEWS","name":"全球不織布與醫療包裝鏈 — 醫用不織布$30.39B→$38.98B","newsDate":"2026/08/18","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1787522886986},"relatedStocks":"3407,DD,7912,546.SI","updatedAt":1787522886486,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522886486,"event":"上海藥監試點：UDI 結合區塊鏈追溯，醫材上市後追溯時效從 14 天縮至 2 天，NMPA 46 項行標與 57 指南要求包裝標籤與追溯數據同步；多地飛檢將查 UDI 賦碼與包裝完整性關聯。","id":"409fda9fd80aaad5a67c2356","impact":"包材標籤錯誤將直接觸發 UDI 不合規，滅菌袋/吸塑印刷與條碼等級需同步確效；具備數位印刷與追溯系統的包材廠門檻墊高。","itemType":"MEDICAL_NEWS","name":"上海UDI+區塊鏈試點 — 14天→2天追溯加速","newsDate":"2026/08/18","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1787522886786},"relatedStocks":"7917,7912,3407","updatedAt":1787522886486,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522886486,"event":"中國醫材包裝協會口徑：2025 年國內無菌包裝市場規模約 120 億人民幣，骨科植入物吸塑與托盤佔 35%，高阻隔薄膜與 Tyvek 類透析紙需求受集採（VBP）推動向國產替代，山東威高、藍帆、新華、穩健等擴產不織布與滅菌包材產能。","id":"5375723ca6cd516491c8e8b5","impact":"集採降價壓縮進口包材議價，國產 Tyvek 替代與吸塑一體化成為趨勢；台日薄膜廠需以 ISO 11607 完整數據與 PPWR 合規切入，否則價格戰落後。","itemType":"MEDICAL_NEWS","name":"中國無菌包裝市場 ~120億人民幣 — 骨科吸塑35%佔比","newsDate":"2026/08/18","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1787522886486},"relatedStocks":"3407,7917,DD","sourceUrl":"https://www.chinameddevice.com/nmpa-roundup-202608/","updatedAt":1787522886486,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522886486,"event":"產業動態：Dawn Z1500 PP 紡粘料用於醫用不織布，恆天等擴產；穩健醫療等頭部廠商 2026 年醫用敷料與包材產能持續釋放，PP 不織布 2025 $8B→2030 CAGR 4.2%（醫療衛生 5.7%），中國佔全球新增產能 40% 以上。","id":"179474bedd562d7c8c8bc5d7","impact":"上游 PP 紡粘供給寬鬆、PP 粒子 $1.22/kg 震盪，壓低醫用不織布成本但加劇同質競爭；具滅菌確效與品牌客戶綁定的包材廠受惠。","itemType":"MEDICAL_NEWS","name":"中國不織布原料擴產 — Dawn Z1500 PP紡粘、穩健醫療產能釋放","newsDate":"2026/08/19","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1787522886586},"relatedStocks":"3407,DD,7912","updatedAt":1787522886486,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522886486,"event":"BD 匈牙利注射器廠 €110M 擴產，歐洲醫材供應鏈在地化加速，呼應 PPWR 本地回收體系要求與近岸外包趨勢；歐洲滅菌包材廠產能利用率回升。","id":"51fd2a62e5e7fec5f25164ba","impact":"歐洲本地化降低跨境包材物流與 PPWR 合規風險，亞洲出口廠需以成本與技術文件優勢維繫訂單，否則面臨轉單。","itemType":"MEDICAL_NEWS","name":"BD匈牙利€110M擴產＋歐洲在地化趨勢","newsDate":"2026/08/15","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1787522887086},"relatedStocks":"FRE,DIM.PA,GETI-B","updatedAt":1787522886486,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522886486,"event":"8 月中旬 PP 粒子亞洲報價約 $1.22/kg 震盪，醫用 CPP/PE 薄膜報價持穩；DuPont Tyvek 醫用透析紙供給平穩未見漲價，滅菌捲/袋報價以長協為主，短期成本端無急漲壓力。","id":"fb84394be35216972986c810","impact":"原料持穩有利包材廠毛利，但 PPWR 單一材質轉換的一次性確效費用（老化/運輸）將成為下半年主要成本增項。","itemType":"MEDICAL_NEWS","name":"PP原料與包材成本波動 — PP $1.22/kg、Tyvek平穩","newsDate":"2026/08/20","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1787522887186},"relatedStocks":"DD,3407,7912,7917","updatedAt":1787522886486,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522886486,"event":"泰國 BOI：2026 H1 獲批投資 1.47 兆泰銖年增，醫療與生技為重點；Thai FDA 推 Medical Device Act 新分類、ASEAN AMDD 調和與 UDI 籌備，馬泰 B/C/D 類互認試點推進，Licensing Facilitation 加速審批。","id":"8fd63de813caf9471d525f75","impact":"泰國成為日韓醫材包材轉移生產基地選項，BOI 稅惠疊加但須同時滿足 Thai FDA 與 UDI 雙合規；本地滅菌包材與手套廠（BOI 優惠）受惠。","itemType":"MEDICAL_NEWS","name":"泰國BOI H1 2026 1.47兆泰銖投資＋AMDD調和與UDI籌備","newsDate":"2026/08/20","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1787522886686},"relatedStocks":"546.SI,3407","updatedAt":1787522886486,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522861869,"event":"LinkedIn 8/12：PPWR 每次包裝變更須重評 EU MDR/IVDR 技術文件、ISO 11607 確效、標籤、風險、滅菌與壽命；ISO/FDIS 11607 預計支援歐盟外市場。有學者提醒 ISO 11607 數據為 PPWR 合規基石，不可割裂。","id":"ed26191760573da34bf7aa98","impact":"單一材質化/增回收含量等永續變更若未同步做 ISO 11607 密封/完整性/老化確效，將觸發 MDR 技術文件不一致而被稽核開立不符合項。","itemType":"MEDICAL_NEWS","name":"PPWR對醫材包裝衝擊解析 — 每次變更需重評MDR/ISO11607/滅菌/壽命","newsDate":"2026/08/15","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1787522862069},"relatedStocks":"DD,DIM.PA,7912,FRE","sourceUrl":"https://www.linkedin.com/pulse/new-ppwr-regulations-what-businesses-must-do-before-12-bhat-rsngf","updatedAt":1787522861869,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522861869,"event":"KAP 8/21：泰國新版醫療投資樞紐國家政策解讀，BOI 促進證書給租稅與非稅優惠但不替代 FDA 許可；Rep Garcia 8/21：2026 泰美貿易投資峰會提及接受 FDA 證書與上市前許可互認討論；BOI 8/19 批准系列措施。","id":"6145fc6a75151e8498856b60","impact":"泰國 BOI 優惠疊加 Thai FDA 許可仍須兩道門檻；FDA 證書互認若落地將加速美械輸泰，但 UDI 與本地代理人要求不變，滅菌包材本地化仍具優勢。","itemType":"MEDICAL_NEWS","name":"泰國醫療投資樞紐新政＋美FDA證書互認磋商","newsDate":"2026/08/21","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1787522862169},"relatedStocks":"546.SI","sourceUrl":"https://www.kap.co.th/thought-leadership/thailands-medical-investment-hub-what-the-new-national-policy-means-for-healthcare-investors/","updatedAt":1787522861869,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522861869,"event":"OpenPR 8/20 兩份報告：全球醫材包裝 2025 $44.12B 預計 2033 達 $101.90B（CAGR 11.7%）；另一口徑 2026 $46.66B 受 EU MDR/ISO 11607 驅動，合規供應商集中度提升。IBISWorld 8 月更新：美國醫材批發業含 Cardinal Health 等龍頭。","id":"5ba447369b53ace49d090a80","impact":"市場高成長＋法規加嚴雙驅動，具 ISO 11607 完整確效與 PPWR 路徑的頭部包材廠（Tyvek/薄膜/無菌袋）議價力提升，中小型廠面臨洗牌。","itemType":"MEDICAL_NEWS","name":"醫材包裝市場規模 $44-46B → $101B（CAGR 11.7%至2033）","newsDate":"2026/08/20","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1787522862269},"relatedStocks":"DD,7912,3407,CAH","sourceUrl":"https://www.openpr.com/news/4609363/medical-device-packaging-market-to-reach-us-101-90-billion","updatedAt":1787522861869,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522861869,"event":"TradeAspectHub 8/17：無菌屏障完整性測試方法與驗證重點（ASTM/ISO 11607），強調滅菌包裝風險與確效優先順序；Getinge 8/14 招募 Staff Engineer Packaging（Wayne NJ）主導 ISO 11607 無菌屏障與防護包裝設計。","id":"9c8b414607e278553bfbecc9","impact":"完整性測試（氣泡/染料/密封強度/老化）成為 QMSR 與 EU MDR 共同稽查重點；具備方法學與數據包的供應商更易通過客戶稽核與 FDA 檢查。","itemType":"MEDICAL_NEWS","name":"無菌屏障完整性測試關鍵方法 — ASTM/ISO11607合規重點","newsDate":"2026/08/17","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1787522862369},"relatedStocks":"GETI-B,STE,DD","sourceUrl":"https://www.tradeaspecthub.com/news/Intelligence_Dimension/MDR_FDA_Regs_UDI_Tracking/Sterile_Barrier_Integrity_Testing_Key_Methods_and_Standards_for_Medical_Packaging.html","updatedAt":1787522861869,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522861869,"event":"Emergo 8/11：NMPA 修訂版《醫療器械生產質量管理規範》11/1/2026 生效。ChinaMedDevice 8/20：7/21 單日發布 57 份終版指南（型檢/非臨床/臨床評價）；Hlongmed 8/14：NMPA 76 號公告發布 46 項行標；中國藥品 GMP 無菌藥品附錄草案同期公開徵求。","id":"9662604aaebb6a39a40aa683","impact":"中國飛檢將依新版 QMS 為準，滅菌包裝確效（ISO 11607 老化/運輸/密封強度數據）與供應商審計要求加嚴；未備原始數據者 11 月後抽檢風險升高。","itemType":"MEDICAL_NEWS","name":"NMPA 11/1新版QMS施行倒數＋7/21單日57份指南＋8/14新版46項行標","newsDate":"2026/08/14","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1787522861869},"relatedStocks":"3407,8086,4543.T","sourceUrl":"https://www.emergobyul.com/news/china-nmpa-quality-management-system-qms-legislation-take-effect-november-1-2026","updatedAt":1787522861869,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522861869,"event":"Mason Ma 8/13：NMPA 7 月批准 323 械（6 月批次）；Asia Actual 8/20：醫美超聲產品分類指南草案擬納 III 類、8/6 徵求截止。ChinaMedDevice 8 月 Roundup 重申 57 指南為合規硬門檻。","id":"ad62e129996806b8650821a4","impact":"審批量回升但技術審評對無菌屏障與包裝完整性要求更細；醫美器械升類將提高臨床與包裝確效門檻，台日供應鏈接單需提前布局。","itemType":"MEDICAL_NEWS","name":"NMPA 7月323械批准＋美粧超聲分類擬納III類（8/6徵求截止）","newsDate":"2026/08/14","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1787522861969},"relatedStocks":"3407,7917","sourceUrl":"https://www.linkedin.com/posts/mason-ma-77152462_nmpajul2026linkedincarousel-activity-7492510056454778880-iZCW","updatedAt":1787522861869,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522861869,"event":"社媒與電商動態：Dawnsens Flash-spun 不織布、Texera 醫用不織布、Chalvo Tyvek 滅菌捲/風琴捲、Modern Care 醫用滅菌紙/透明膜/Tyvek 卷材供應穩定；未見 DuPont Tyvek 停供或漲價訊號。Beckers ASC 8/13：供應鏈隱形稅與結構性壓力為 2026 主調。","id":"c96cf8377f22c018ef9cfc09","impact":"滅菌包材原料供需平穩，短期無斷鏈風險；PPWR 單一材質化與回收含量要求將成為下一輪議價與認證焦點，非價格波動。","itemType":"MEDICAL_NEWS","name":"滅菌與不織布鏈動態 — Tyvek/Spunbond 需求持穩、供給無虞","newsDate":"2026/08/20","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1787522862469},"relatedStocks":"DD,3407,7917","sourceUrl":"https://www.beckersasc.com/supply-chain/supply-chain-updates-2026/","updatedAt":1787522861869,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522861869,"event":"Cisema 8/20：馬來西亞 MDA 8/5 宣布分階段導入全息安全標籤；Mecanmed 8/19-21 菲律賓醫療展、Indorama 1H26 業績改善提及醫材需求。","id":"8531849fb5562bf33e3d5eea","impact":"東南亞 UDI/防偽加嚴與展會需求回溫，利好已布局泰國/大馬的滅菌包材與手套廠（Medtecs 等），但須同步滿足 PPWR 與當地標籤雙合規。","itemType":"MEDICAL_NEWS","name":"馬來西亞MDA 8/5全息防偽標＋印尼/菲律賓醫材展鏈結東南亞需求","newsDate":"2026/08/20","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1787522862569},"relatedStocks":"546.SI","sourceUrl":"https://cisema.com/news/medical-device-hologram-label-malaysia","updatedAt":1787522861869,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522840216,"event":"FDALawBlog 8/12、Pure Global 8/13：FDA 首批 QMSR 警告信曝光 — Linemaster Switch Corp 5/27/2026、Koven Technologies 7/21/2026。前者供應商管理/設計變更/客訴 CAPA 缺失；後者 ISO 13485/QMSR 落差被點名。QMSR 2/2/2026 起納入 ISO 13485:2016 成為檢查重點。","id":"33e66f690a8325e2e46c5d4c","impact":"QMSR 執法正式啟動，供應商控制、設計變更、風險管理成高頻缺失；滅菌包裝供應商若未備齊 6 大證據要素，恐成客戶稽核連帶風險。PPWR 已生效後雙重合規壓力升高。","itemType":"MEDICAL_NEWS","name":"FDA QMSR首批警告信曝光 — Linemaster 5/27、Koven 7/21","newsDate":"2026/08/13","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1787522840616},"relatedStocks":"MDLN,STE,GETI-B","sourceUrl":"https://www.thefdalawblog.com/2026/08/the-qmsr-is-here-fdas-first-qmsr-warning-letters/","updatedAt":1787522840216,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522840216,"event":"8/21 MDLN +5.16% 至 $34.26（32.58→34.26，盤中 34.335/32.51，量 698 萬）。8/20 創 52 週新低 $32.76 後強彈，盤後持平 $34.25。距 8/14 $35.74 仍 -4.14%。MarketBeat/Medline 8/18 披露 $243M 關稅退稅推升 Q2 營收 $7.69B+11.6% 但淨利 -58%。","id":"8c5d57ccff7a7e2ac41c11d2","impact":"短線技術反彈但仍處低檔；火災後倉儲復原與 EBITDA 指引、大股東拋售消化為關鍵。Tyvek 醫療包材龍頭波動牽動整體滅菌包裝鏈情緒。","itemType":"MEDICAL_NEWS","name":"MDLN 8/21 強彈 +5.16% 至 $34.26 — 52 週低 $32.76 後反彈","newsDate":"2026/08/21","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1787522840216},"relatedStocks":"MDLN","sourceUrl":"https://www.marketbeat.com/instant-alerts/medline-nasdaqmdln-reaches-new-52-week-low-time-to-sell-2026-08-20/","updatedAt":1787522840216,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522840216,"event":"Frey Solutions 8/19：PPWR 8/12 起 PFAS 包材限制與 Substances of Concern（SoC）要求強制，供應商與製造商責任分工明確，無統一 SoC 限值、採逐案揭露；KPFilms 8/20 指藥品/醫材包裝須評估永續、回收性與材料用量；EU Facebook 8/12 官宣新規則今日起適用但非一次到位。","id":"d1806f45c687697283f80cf3","impact":"醫材包材 PFAS/重金屬/SoC 揭露成為 DoC 必備；Tyvek/薄膜供應商需提供完整成分與回收路徑聲明，否則下游醫材廠無法完成技術文件與標籤。","itemType":"MEDICAL_NEWS","name":"PPWR物質關注與PFAS限制 8/12起強制 — 供應商責任明確","newsDate":"2026/08/12","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"a21e924915816dd70e4e145e":1787522840916},"relatedStocks":"DD,3407,7912","sourceUrl":"https://www.freyrsolutions.com/blog/ppwr-substances-of-concern-what-changes-from-august-2026","updatedAt":1787522840216,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522840216,"event":"8/21 ACH -8.40% 至 $1.20（1.31→1.20，高點 1.305/低點 1.175，量 161 萬）。52 週高 $5.69/低 $0.93，距 8/14 $0.95 反彈後再度轉弱，流動性低、日內振幅大。","id":"eb6a441e21db2ec615dc8a28","impact":"小盤醫療耗材股持續受獲利與 Nasdaq $1 合規擔憂壓抑；反彈可持續性低，族群連動有限。","itemType":"MEDICAL_NEWS","name":"ACH 8/21 續跌 -8.40% 至 $1.20 低檔震盪","newsDate":"2026/08/21","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1787522840316},"relatedStocks":"ACH","sourceUrl":"https://finance.yahoo.com/quote/ACH/","updatedAt":1787522840216,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1787522840216,"event":"8/21 美股分化：STE +0.93% 至 $237.93（238.55/235.47 量 30.7 萬）逼近 52 週高 $269.44；MDT +1.14% 至 $93.35 放量 749 萬強勢；SNN +0.76% 至 $29.26 小反彈；DD -0.09% 至 $138.33（141.0 高點回落量 111 萬）；CAH +0.46% 至 $229.51 高檔震盪。","id":"7155c1e71270f6a757208234","impact":"滅菌設備（STE/Getinge）與綜合醫材（MDT）相對抗跌；Tyvek 原料 DD 回落反映 PPWR 單一材質趨勢下的短期獲利了結，長線仍受惠。","itemType":"MEDICAL_NEWS","name":"美股醫療包材鏈分化 — STE +0.93%、MDT +1.14% 領漲","newsDate":"2026/08/21","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1787522840416},"relatedStocks":"STE,MDT,SNN,DD,CAH","sourceUrl":"https://finance.yahoo.com/quotes/","updatedAt":1787522840216,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1786933533446,"deletedAt":null,"id":"default_medical_stock_folder_6a3d974d01591e0e744b8c","isNew":false,"isPublic":false,"itemType":"MEDICAL_STOCK_FOLDER","name":"醫療概念股掃描","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"medicalConcept":1786933533446},"preParentID":null,"reviewedAt":0,"updatedAt":1786933533446,"updatedBy":{"userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":1},{"createdAt":1782694647350,"id":"a21e924915816dd70e4e145e","itemType":"MEDICAL_STOCK_FOLDER","name":"醫療法規追蹤","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"medicalConcept":1782694647350},"updatedAt":1782694647350,"version":1},{"createdAt":1782499224929,"id":"73b2d5753f264af9d8d1409e","itemType":"MEDICAL_STOCK_FOLDER","name":"醫療概念股掃描","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"medicalConcept":1782499224929},"updatedAt":1782499224929,"version":1},{"changePercent":-2.52,"country":"東南亞","createdAt":1782499582664,"id":"1910727b98ee53de38be730e","itemType":"MEDICAL_STOCK","marketCap":"SGD62.67M（估算）","name":"Medtecs","note":"9/4 +6.14% 至 SGD 0.121（0.114→0.121），vs 8/28 +6.14% 本週最強。9/4放量跳漲突破0.12。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1782499582964},"price":"SGD0.116","product":"PPE、隔離衣、手術服","scanDate":"2026-09-18","stockCode":"546.SI","stockName":"Medtecs（美德醫）","updatedAt":1789942178731,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":58},{"changePercent":-0.68,"country":"美國","createdAt":1784588827550,"id":"d2401185f7815f2fe152a84e","itemType":"MEDICAL_STOCK","marketCap":"$117.27B（估算）","name":"MDT","note":"9/4 +1.15% 至 $94.17（93.10→94.17），vs 8/28 +3.22%。9/1 FY27 Q1營收$9.76B +13.7% beat並上調全年有機成長至7.25-7.75%，財報後連漲。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1784588827550},"price":"$92.13","product":"醫療器材綜合大廠（心臟節律器、神經調節、手術機器人、糖尿病護理）","scanDate":"2026-09-18","stockCode":"MDT","stockName":"Medtronic PLC","updatedAt":1789942178731,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":32},{"changePercent":-0.79,"country":"英國","createdAt":1784588827550,"id":"e10e11f49ef004f005e9a0e2","itemType":"MEDICAL_STOCK","marketCap":"$11.54B（估算）","name":"SNN","note":"9/4 +0.63% 至 $28.87（28.69→28.87），vs 8/28 -0.35%。29關下窄幅震盪。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1784588827650},"price":"$27.56","product":"骨科植入物、傷口照護、運動醫學、手術器械","scanDate":"2026-09-18","stockCode":"SNN","stockName":"Smith \u0026 Nephew PLC","updatedAt":1789942178731,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":32},{"changePercent":-1.26,"country":"日本","createdAt":1782516789564,"id":"969cbe7234b119e4a221f0c5","itemType":"MEDICAL_STOCK","marketCap":"¥1.27T（估算）","name":"7912","note":"9/4 +0.43% 至 ¥3,056（3043→3056），vs 8/28 -1.20%。9/2跌破3040後連兩日小彈。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1782516789564},"price":"¥2,960.5","product":"滅菌包材、醫療包裝（回收單一材質滅菌袋）","revenue":"▲ ¥357B","scanDate":"2026-09-18","stockCode":"7912","stockName":"Dai Nippon Printing（大日本印刷）","updatedAt":1789942178731,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":49},{"changePercent":-1.27,"country":"日本","createdAt":1784588827550,"id":"b4b9b7267b7bc8e7112ee857","itemType":"MEDICAL_STOCK","marketCap":"¥92.93B（估算）","name":"7917","note":"9/4 +0.32% 至 ¥1,252（1248→1252），vs 8/28 -2.19%。9/2跌破1255後暫止穩，日股中相對抗跌。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1784588827750},"price":"¥1,240","product":"醫療滅菌包材（Medic系列）、工業用薄膜、醫藥包裝","scanDate":"2026-09-18","stockCode":"7917","stockName":"Zacros Corp（前Fujimori Kogyo）","updatedAt":1789942178731,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":32},{"changePercent":-2.04,"country":"日本","createdAt":1782499234019,"id":"f47db74d81fec0b408129136","itemType":"MEDICAL_STOCK","marketCap":"¥249.78B（估算）","name":"8086","note":"9/4 -2.00% 至 ¥1,470（1500→1470），vs 8/28 -3.80% 日股最弱。8/27起連跌，跌破1500關口。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1782499234519},"price":"¥1,443","product":"醫材包材/血管介入","scanDate":"2026-09-18","stockCode":"8086","stockName":"Nipro Corp","updatedAt":1789942178731,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":60},{"changePercent":-3.24,"country":"日本","createdAt":1782534170568,"id":"168b965c666f24bfe4fefdc7","itemType":"MEDICAL_STOCK","marketCap":"¥3.23T（估算）","name":"Terumo","note":"9/4 -1.44% 至 ¥2,432（2467.5→2432），vs 8/28 -4.21%。9/2跳水後連跌，跌破2450。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1782534170668},"price":"¥2,238","product":"醫療器材綜合大廠，含滅菌產品、輸液系統、心血管介入","scanDate":"2026-09-18","stockCode":"4543.T","stockName":"Terumo Corp","updatedAt":1789942178731,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":53},{"changePercent":-1.67,"country":"瑞典","createdAt":1784588827550,"id":"342dc4444c9e2be7cc710ab7","itemType":"MEDICAL_STOCK","marketCap":"SEK59.85B（估算）","name":"Getinge","note":"9/4 -0.98% 至 SEK 241.80（244.2→241.8），vs 8/28 -2.26%。240關口附近震盪。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1784588827850},"price":"SEK236.20","product":"滅菌設備與感染控制、手術系統、心血管設備","scanDate":"2026-09-18","stockCode":"GETI-B","stockName":"Getinge AB","updatedAt":1789942178731,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":31},{"changePercent":-0.74,"country":"日本","createdAt":1782499234019,"id":"f48eb9577c005d486a4d2d0e","itemType":"MEDICAL_STOCK","marketCap":"¥2.23T（估算）","name":"3407","note":"9/4 -2.54% 至 ¥1,612（1654→1612），vs 8/28 -0.22%。9/1衝1688.5後連跌三日回吐。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1782499234419},"price":"¥1,600","product":"醫療不織布材料","scanDate":"2026-09-18","stockCode":"3407","stockName":"Asahi Kasei（旭化成）","updatedAt":1789942178731,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":60},{"changePercent":1.3,"country":"台灣","createdAt":1782525407525,"id":"b4aff0fb0ef02478fdaee581","itemType":"MEDICAL_STOCK","marketCap":"NT$9.03B（估算）","name":"8215","note":"9/4 +0.99% 至 NT$25.55（25.30→25.55），vs 8/28 -2.48%。9/2彈至26.30後高檔震盪，守住25.5。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1782525407525},"price":"NT$27.35","product":"滅菌包材（聯和醫材 SIGMA 品牌）","scanDate":"2026-09-18","stockCode":"8215","stockName":"明基材（BenQ Materials）","updatedAt":1789942178731,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":55},{"changePercent":-0.48,"country":"德國","createdAt":1784588827550,"id":"bdefe44044d43d11a6fb666d","itemType":"MEDICAL_STOCK","marketCap":"€25.87B（估算）","name":"Fresenius","note":"9/4 -1.33% 至 €43.63（44.22→43.63），vs 8/28 -4.84% 歐股最弱。8/26起連六黑。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1784588827950},"price":"€45.92","product":"透析用品、醫院管理、輸液藥品、滅菌耗材","scanDate":"2026-09-18","stockCode":"FRE","stockName":"Fresenius SE \u0026 Co KGaA","updatedAt":1789942178731,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":31},{"changePercent":2.17,"country":"法國","createdAt":1782534170568,"id":"447689d69834bb5d5084d2d5","itemType":"MEDICAL_STOCK","marketCap":"€18.58B（估算）","name":"Sartorius Stedim Biotech","note":"9/4 -4.18% 至 €190.30（198.6→190.3），vs 8/28 -3.74%。9/4單日重挫跌破190，前三日連漲全數回吐。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1782534170568},"price":"€198.10","product":"生物製藥過濾、流體管理與無菌製程設備","revenue":"FY2026 營收成長預估 6-10%（固定匯率）","scanDate":"2026-09-18","stockCode":"DIM.PA","stockName":"Sartorius Stedim Biotech SA","updatedAt":1789942178731,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":51},{"changePercent":-1.5,"country":"美國","createdAt":1782499234019,"id":"d285736156eebbdc2c571688","itemType":"MEDICAL_STOCK","marketCap":"$39.95B（估算）","name":"MDLN","note":"9/4 持平 $36.59（36.59→36.59），vs 8/28 +3.71%。9/2跳漲至36.30後高檔橫盤，續創IPO來新高區。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1782499234019},"price":"$31.64","product":"滅菌手術服、包材、手術鋪單","scanDate":"2026-09-18","stockCode":"MDLN","stockName":"Medline Industries","updatedAt":1789942178731,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":61},{"changePercent":-4.26,"country":"美國","createdAt":1782499234019,"id":"da0a2494d5b3ab7528e1c116","itemType":"MEDICAL_STOCK","marketCap":"$52.57B（估算）","name":"CAH","note":"9/4 -0.58% 至 $247.18（248.61→247.18），vs 8/28 +5.39% 本週最強美股。9/1-3連漲四日後小回，CGM/泌尿布局題材。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1782499234119},"price":"$225.38","product":"醫療耗材經銷、手術服","revenue":"Q4 FY2026 $63.7B (+6% YoY)","scanDate":"2026-09-18","stockCode":"CAH","stockName":"Cardinal Health","updatedAt":1789942178731,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":60},{"changePercent":-1.44,"country":"美國","createdAt":1782499234019,"id":"b38a1eec9c7518a969be5e1b","itemType":"MEDICAL_STOCK","marketCap":"$20.27B（估算）","name":"STE","note":"9/4 -0.99% 至 $224.59（226.83→224.59），vs 8/28 -3.93% 本週最弱美股。9/1起連四黑，跌破230關口。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1782499234219},"price":"$205.04","product":"滅菌設備與耗材","revenue":"FY2026 $5.9B (+9% YoY)","scanDate":"2026-09-18","stockCode":"STE","stockName":"STERIS plc","updatedAt":1789942178731,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":60},{"changePercent":0.43,"country":"美國","createdAt":1782500707418,"id":"801cad26cfcf939c7973e91e","itemType":"MEDICAL_STOCK","marketCap":"$17.20B（估算）","name":"DD","note":"9/4 +0.35% 至 $131.59（131.13→131.59），vs 8/28 -3.94%。8/31起連跌後暫止穩，守住131。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1782500707418},"price":"$129.01","product":"Tyvek 醫療包材原料、不織布","scanDate":"2026-09-18","stockCode":"DD","stockName":"DuPont de Nemours","updatedAt":1789942178731,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":56},{"changePercent":-13.59,"country":"美國","createdAt":1782499234019,"id":"d609bb66b40d3f646c87d9de","itemType":"MEDICAL_STOCK","marketCap":"$89.00M（估算）","name":"ACH","note":"9/4 -0.82% 至 $1.21（1.22→1.21），vs 8/28持平。9/5 8-K：CEO繼任9月中前公布；Baird降評Neutral目標$1.50。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1782499234319},"price":"$0.89","product":"醫療耗材、手術服","scanDate":"2026-09-18","stockCode":"ACH","stockName":"Accendra Health（原 Owens \u0026 Minor）","updatedAt":1789942178731,"updatedBy":{"agentId":"2c986f4cb386fbdf363ceedc","agentName":"醫療掃描員","userId":"6a3d974d01591e0e744b8c","userName":"Ivan"},"version":59},{"changePercent":0,"country":"日本","createdAt":1782499234019,"id":"17b0a69b068dc5b196bc15e0","itemType":"MEDICAL_STOCK","marketCap":"已下市","name":"3593","note":"⚠️ 已下市！2026/5/15 自東京證交所下市。Carlyle Group 收購。最後交易價 ¥6,660。無需掃描。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1782499234619},"price":"¥6,660","product":"滅菌包材、手術服","scanDate":"2026-07-13","stockCode":"3593","stockName":"Hogy Medical（保木醫療）","updatedAt":1783903015147,"version":14},{"changePercent":0,"country":"東南亞","createdAt":1782499582664,"id":"789729591dc3f73722cbe3f0","itemType":"MEDICAL_STOCK","marketCap":"—","name":"Stevimed","note":"7/9掃描。越南未上市。拋棄式醫材出口歐美。越南 Decree 37/2026 新標籤規範提高進口門檻。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1782499583064},"price":"未上市","product":"手術服、鋪單、醫療包材","scanDate":"2026-07-13","stockCode":"—","stockName":"Stevimed Medical JSC","updatedAt":1783903015147,"version":14},{"changePercent":0,"country":"歐洲","createdAt":1782499582664,"id":"7e1bc62d8302f9dc96e23909","itemType":"MEDICAL_STOCK","marketCap":"—","name":"Lohmann-Rauscher","note":"7/9掃描。奧地利未上市。歐系醫療耗材製造商。IndexBox 全球壓縮治療設備報告列入主要廠商。PPWR 8/12 生效（34天）催化劑。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1782499582764},"price":"未上市","product":"醫療包材、滅菌產品、手術服","scanDate":"2026-07-13","stockCode":"—","stockName":"Lohmann \u0026 Rauscher","updatedAt":1783903015147,"version":14},{"changePercent":0,"country":"歐洲","createdAt":1782499582664,"id":"89ddb0889fd5edbdfa3cfe79","itemType":"MEDICAL_STOCK","marketCap":"—","name":"Molnlycke","note":"7/10掃描。瑞典未上市。手術鋪單/滅菌包材領導廠。捷克廠 2026 年初投產、產能達 1 億組/年。PPWR 催化劑。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1782499582864},"price":"未上市","product":"手術服、傷口照護、滅菌產品","scanDate":"2026-07-13","stockCode":"—","stockName":"Mölnlycke Health Care","updatedAt":1783903015147,"version":14},{"changePercent":0,"country":"比利時","createdAt":1782534170568,"id":"e69bc4f2191fe8f8f38c2696","itemType":"MEDICAL_STOCK","marketCap":"—","name":"Nelipak","note":"7/10掃描。比利時總部未上市。愛爾蘭 Clara 廠 6/30 獲 ISCC PLUS 永續認證（歐洲第二據點）。哥斯大黎加新廠 2026 年中開幕。全球 14 據點。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1782534170768},"price":"未上市","product":"醫療等級無菌屏障包材（硬式/軟式）","scanDate":"2026-07-13","stockCode":"—","stockName":"Nelipak Healthcare Packaging","updatedAt":1783903015147,"version":11},{"changePercent":0,"country":"歐洲","createdAt":1782499582664,"id":"88e49f428da1be21a981c561","itemType":"MEDICAL_STOCK","marketCap":"—","name":"Hartmann","note":"7/10掃描。德國未上市。歐系醫療耗材/滅菌包材製造商。IndexBox 全球壓縮治療設備報告入列主要廠商。PPWR 8/12 生效（34天）為包材合規催化劑。","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","parents":{"73b2d5753f264af9d8d1409e":1782499582664},"price":"未上市","product":"醫療耗材、滅菌包材、手術服","scanDate":"2026-07-13","stockCode":"—","stockName":"Paul Hartmann AG","updatedAt":1783903015147,"version":15},{"changePercent":0,"createdAt":1782534162738,"id":"89dd0889fd5edbdfa3cfe79","itemType":"MEDICAL_STOCK","marketCap":"—","name":"","note":"瑞典 Investor AB 旗下；全球手術服龍頭，年營收約 €2B；慶祝 1 億個 ProcedurePak 托盤里程碑","originPluginDir":"醫療概念股面板","originPluginID":"cad183ec663244f61c1f6258","price":"未上市","scanDate":"2026-06-27","updatedAt":1782534162738,"version":1}]}